Grove Collaborative (GROV) 10-Q 10 Nov 22 2022 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2022	Nov. 04, 2022
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-40263
Entity Registrant Name	Grove Collaborative Holdings, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	88-2840659
Entity Address, Address Line One	1301 Sansome Street
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94111
City Area Code	800
Local Phone Number	231-8527
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Central Index Key	0001841761
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false
Class A Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Class A common stock, par value $0.0001
Trading Symbol	GROV
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		86,370,812
Common stock warrants
Entity Information [Line Items]
Title of 12(b) Security	Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
Trading Symbol	GROV.WS
Security Exchange Name	NYSE
Class B Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		80,627,804

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 103,791	$ 78,376
Inventory, net	56,045	54,453
Prepaid expenses and other current assets	7,240	8,104
Total current assets	167,076	140,933
Property and equipment, net	15,390	15,932
Operating lease right-of-use assets	18,628	21,214
Other long-term assets	2,097	4,394
Total assets	203,191	182,473
Current liabilities:
Accounts payable	13,642	21,346
Accrued expenses	35,809	20,651
Deferred revenue	10,816	11,267
Operating lease liabilities, current	3,820	3,550
Other current liabilities	863	1,650
Debt, current	28,447	10,750
Total current liabilities	93,397	69,214
Debt, noncurrent	37,773	56,183
Operating lease liabilities, noncurrent	17,089	20,029
Derivative liabilities	27,737	0
Other long-term liabilities	2,160	5,408
Total liabilities	178,156	150,834
Commitments and contingencies (Note 7)
Convertible preferred stock, $0.0001 par value – 100,000,000 and 115,527,580 shares authorized at September 30, 2022 and December 31, 2021, respectively; no and 114,795,034 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively	0	487,918
Stockholders’ equity (deficit):
Common stock - Class A shares, $0.0001 par value – 600,000,000 shares authorized at September 30, 2022 and no shares authorized at December 31, 2021; 70,039,246 and no shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively; Class B shares, $0.0001 par value – 200,000,000 and 194,046,918 shares authorized at September 30, 2022 and December 31, 2021, respectively; 96,181,701 and 9,368,167 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively	16	1
Additional paid-in capital	590,194	33,863
Accumulated deficit	(565,175)	(490,143)
Total stockholders’ equity (deficit)	25,035	(456,279)
Total liabilities, convertible preferred stock and stockholders’ equity (deficit)	$ 203,191	$ 182,473

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets - Parenthetical - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Temporary equity, par value (in dollars per share)	$ 0.0001	$ 0.0001
Temporary equity, shares authorized (in shares)	100,000,000	115,527,580
Temporary equity, shares issued (in shares)	0	114,795,034
Temporary equity, shares outstanding (in shares)	0	114,795,034
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	600,000,000	0
Common stock, shares issued (in shares)	70,039,246	0
Common stock, shares outstanding (in shares)	70,039,246	0
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	200,000,000	194,046,918
Common stock, shares issued (in shares)	96,181,701	9,368,167
Common stock, shares outstanding (in shares)	96,181,701	9,368,167

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues [Abstract]
Revenue, net	$ 77,733	$ 95,178	$ 247,491	$ 296,421
Cost of goods sold	39,566	47,194	127,630	147,179
Gross profit	38,167	47,984	119,861	149,242
Operating Expenses [Abstract]
Advertising	8,668	32,459	59,359	90,611
Product development	5,765	5,586	17,927	16,436
Selling, general and administrative	46,295	46,100	155,160	140,609
Operating loss	(22,561)	(36,161)	(112,585)	(98,414)
Interest expense	2,546	1,213	6,918	3,272
Loss on extinguishment of debt	0	0	0	1,027
Change in fair value of Additional Shares liability	(1,045)	0	970	0
Change in fair value of Earn-Out liability	(28,791)	0	(46,136)	0
Change in fair value of Public and Private Placement Warrants liability	(2,803)	0	(3,983)	0
Other expense, net	(140)	113	4,643	1,157
Interest and other expense (income), net	(30,233)	1,326	(37,588)	5,456
Income (loss) before provision for income taxes	7,672	(37,487)	(74,997)	(103,870)
Provision for income taxes	10	11	35	39
Net income (loss)	$ 7,662	$ (37,498)	$ (75,032)	$ (103,909)
Net income (loss) per share attributable to common stockholders, basic (in dollars per share)	$ 0.05	$ (4.24)	$ (1.13)	$ (12.42)
Net income (loss) per share attributable to common stockholders, diluted (in dollars per share)	$ 0.05	$ (4.24)	$ (1.13)	$ (12.42)
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic (in shares)	154,995,402	8,837,011	66,393,538	8,366,464
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted (in shares)	166,104,259	8,837,011	66,393,538	8,366,464

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders’ Equity (Deficit) - USD ($) $ in Thousands		Total	Previously Reported	Convertible Preferred Stock		Convertible Preferred Stock Previously Reported		Convertible Preferred Stock Revision of Prior Period, Adjustment		Contingently Redeemable Convertible Common Stock		Contingently Redeemable Convertible Common Stock Previously Reported	[3]	Common Stock		Common Stock Previously Reported		Common Stock Revision of Prior Period, Adjustment	Additional Paid-In Capital	Additional Paid-In Capital Previously Reported	Accumulated Deficit	Accumulated Deficit Previously Reported
Temporary equity, balances at beginning of period (in shares) at Dec. 31, 2020	[1]			114,795,000		97,611,000		17,184,000
Temporary equity, balances at beginning of period at Dec. 31, 2020	[1]			$ 487,918		$ 487,918
Temporary equity, balances at ending of period (in shares) at Sep. 30, 2021	[1],[2]			114,795,000
Temporary equity, balances at ending of period at Sep. 30, 2021	[1],[2]			$ 487,918
Balances at beginning of period (in shares) at Dec. 31, 2020	[1]													8,468,000		7,200,000		1,268,000
Balances at beginning of period at Dec. 31, 2020		$ (339,641)	$ (339,641)											$ 1	[1]	$ 1	[1]		$ 14,605	$ 14,605	$ (354,247)	$ (354,247)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of preferred stock warrant liability to common stock warrants		1,622																	1,622
Issuance of common stock upon exercise of warrants (in shares)														286,000
Issuance of common stock upon exercise of warrants		150																	150
Issuance of common stock for services (in shares)	[1]													4,000
Issuance of common stock for services		49																	49
Issuance of common stock upon exercise of stock options (in shares)	[1]													581,000
Issuance of common stock upon exercise of stock options		591																	591
Vesting of early exercise of options		1,413																	1,413
Repurchase of early exercised options (in shares)	[1]													(155,000)
Stock-based compensation		11,007																	11,007
Net income (loss)		(103,909)																			(103,909)
Balances at ending of period (in shares) at Sep. 30, 2021	[1],[2]													9,184,000
Balances at ending of period at Sep. 30, 2021		(428,718)												$ 1	[1],[2]				29,437		(458,156)
Temporary equity, balances at beginning of period (in shares) at Jun. 30, 2021	[2]			114,795,000		97,611,000		17,184,000
Temporary equity, balances at beginning of period at Jun. 30, 2021	[2]			$ 487,918		$ 487,918
Temporary equity, balances at ending of period (in shares) at Sep. 30, 2021	[1],[2]			114,795,000
Temporary equity, balances at ending of period at Sep. 30, 2021	[1],[2]			$ 487,918
Balances at beginning of period (in shares) at Jun. 30, 2021	[2]													8,839,000		7,516,000		1,323,000
Balances at beginning of period at Jun. 30, 2021		(395,275)	(395,275)											$ 1	[2]	$ 1	[2]		25,382	25,382	(420,658)	(420,658)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of warrants (in shares)														286,000
Issuance of common stock upon exercise of warrants		150																	150
Issuance of common stock upon exercise of stock options (in shares)	[2]													59,000
Issuance of common stock upon exercise of stock options		74																	74
Vesting of early exercise of options		168																	168
Stock-based compensation		3,663																	3,663
Net income (loss)		(37,498)																			(37,498)
Balances at ending of period (in shares) at Sep. 30, 2021	[1],[2]													9,184,000
Balances at ending of period at Sep. 30, 2021		$ (428,718)												$ 1	[1],[2]				29,437		(458,156)
Temporary equity, balances at beginning of period (in shares) at Dec. 31, 2021		114,795,034		114,795,000	[3]	97,611,000	[3]	17,184,000	[3]	0	[3]	0
Temporary equity, balances at beginning of period at Dec. 31, 2021		$ 487,918		$ 487,918	[3]	$ 487,918	[3]			$ 0	[3]	$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of preferred stock and common stock upon net exercise of warrants ( in shares)	[3]			168,000
Issuance of preferred stock and common stock upon exercise of warrants	[3]			$ 989
Convertible preferred stock and contingently redeemable common stock conversion (in shares)	[3]			(114,963,000)						(2,750,000)
Convertible preferred stock and contingently redeemable common stock conversion	[3]			$ (488,907)						$ (27,473)
Issuance of convertible common stock (in shares)	[3]									2,750,000
Issuance of convertible common stock	[3]									$ 27,473
Temporary equity, balances at ending of period (in shares) at Sep. 30, 2022		0		0	[3],[4]					0	[3],[4]
Temporary equity, balances at ending of period at Sep. 30, 2022		$ 0		$ 0	[3],[4]					$ 0	[3],[4]
Balances at beginning of period (in shares) at Dec. 31, 2021	[3]													9,368,000		7,966,000		1,402,000
Balances at beginning of period at Dec. 31, 2021		(456,279)	$ (456,279)											$ 1	[3]	$ 1	[3]		33,863	$ 33,863	(490,143)	$ (490,143)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares under ELOC Agreement (in shares)														41,000
Issuance of shares under ELOC Agreement		138																	138
Issuance of preferred stock and common stock upon net exercise of warrants (in shares)	[3]													180,000
Issuance of preferred stock and common stock upon exercise of warrants		12																	12
Conversion of preferred stock warrant liability to common stock warrants		2,182																	2,182
Convertible preferred stock and contingently redeemable common stock conversion (in shares)	[3]													118,205,000
Convertible preferred stock and contingently redeemable common stock conversion		516,380												$ 12	[3]				516,368
Issuance of common stock in connection with Business Combination, net of $17.8 million in transaction costs (in shares)	[3]													20,921,000
Issuance of common stock in connection with Business Combination, net of $17.6 million in transaction costs		79,468												$ 2	[3]				79,466
Additional Shares liability, Earn-Out liability and Public and Private Placement Warrants recognized upon Business Combination		(93,196)																	(93,196)
Issuance of Earn-Out Shares (in shares)	[3]													14,000,000
Issuance of Earn-Out Shares		1												$ 1	[3]
Issuance of Class A common stock issued to employees, net of withholding taxes (in shares)	[3]													32,000
Issuance of Class A common stock issued to employees, net of withholding taxes		(96)																	(96)
Issuance of shares to settle additional shares liability (in shares)														3,275,000
Issuance of shares to settle Additional Shares Liability		$ 16,310																	16,310
Issuance of common stock upon exercise of stock options (in shares)		216,856												216,000	[3]
Issuance of common stock upon exercise of stock options		$ 354																	354
Vesting of early exercise of options		125																	125
Repurchase of early exercised options (in shares)	[3]													(17,000)
Stock-based compensation		34,668																	34,668
Net income (loss)		(75,032)																			(75,032)
Balances at ending of period (in shares) at Sep. 30, 2022	[3],[4]													166,221,000
Balances at ending of period at Sep. 30, 2022		$ 25,035												$ 16	[3],[4]				590,194		(565,175)
Temporary equity, balances at beginning of period (in shares) at Jun. 30, 2022	[4]			0						0
Temporary equity, balances at beginning of period at Jun. 30, 2022	[4]			$ 0						$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of shares under ELOC Agreement (in shares)	[4]			0
Issuance of shares under ELOC Agreement	[4]			$ 0
Temporary equity, balances at ending of period (in shares) at Sep. 30, 2022		0		0	[3],[4]					0	[3],[4]
Temporary equity, balances at ending of period at Sep. 30, 2022		$ 0		$ 0	[3],[4]					$ 0	[3],[4]
Balances at beginning of period (in shares) at Jun. 30, 2022	[4]													162,870,000
Balances at beginning of period at Jun. 30, 2022		(8,478)												$ 16	[4]				564,343		(572,837)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares under ELOC Agreement (in shares)	[4]													41,000
Issuance of shares under ELOC Agreement		138																	138
Issuance of common stock in connection with Business Combination, net of $17.6 million in transaction costs		(513)																	(513)
Issuance of shares to settle additional shares liability (in shares)														3,275,000
Issuance of shares to settle Additional Shares Liability		16,310																	16,310
Issuance of common stock upon exercise of warrants (in shares)														24,000
Issuance of common stock upon exercise of warrants		12																	12
Issuance of common stock upon exercise of stock options (in shares)	[4]													11,000
Issuance of common stock upon exercise of stock options		21																	21
Stock-based compensation		9,883																	9,883
Net income (loss)		7,662																			7,662
Balances at ending of period (in shares) at Sep. 30, 2022	[3],[4]													166,221,000
Balances at ending of period at Sep. 30, 2022		$ 25,035												$ 16	[3],[4]				$ 590,194		$ (565,175)
[1] (1) The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3. (1) The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3. The accompanying notes are an integral part of these condensed consolidated financial statements. (1) The shares of the Company’s common, convertible preferred stock and contingently redeemable convertible common stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3. The accompanying notes are an integral part of these condensed consolidated financial statements.

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders’ Equity (Deficit) - Parenthetical $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($)
Reverse recapitalization, transaction costs net	$ 17.6

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities
Net income (loss)	$ (75,032)	$ (103,909)
Adjustments to reconcile net loss to net cash used in operating activities:
Remeasurement of convertible preferred stock warrant liability	(1,616)	1,526
Stock-based compensation	34,348	10,858
Depreciation and amortization	4,291	3,633
Changes in fair value of derivative liabilities	(49,149)	0
Transaction costs allocated to derivative liabilities upon Business Combination	6,873	0
Non-cash interest expense	447	509
Inventory reserve	3,540	1,933
Loss on extinguishment of debt	0	1,027
Other non-cash expenses	170	396
Changes in operating assets and liabilities:
Inventory	(5,132)	(14,819)
Prepaids and other assets	715	(2,081)
Accounts payable	(7,550)	7,400
Accrued expenses	(1,826)	5,431
Deferred revenue	(451)	159
Operating lease right-of-use assets and liabilities	(84)	62
Other liabilities	909	(878)
Net cash used in operating activities	(89,547)	(88,753)
Cash Flows from Investing Activities
Purchase of property and equipment	(3,580)	(4,268)
Net cash used in investing activities	(3,580)	(4,268)
Cash Flows from Financing Activities
Proceeds from issuance of common stock upon Closing of Business Combination	97,100	0
Proceeds from issuance of contingently redeemable convertible common stock	27,500	0
Proceeds from issuance of shares under the ELOC Agreement	138	0
Payment of transaction costs related to the Closing of the Business Combination, the ELOC Agreement and convertible preferred stock issuance costs	(5,358)	(340)
Proceeds from the issuance of debt	0	50,000
Repayment of debt	(865)	(21,523)
Payment of debt issuance costs	(211)	(375)
Payment of debt extinguishment	0	(2,499)
Proceeds from exercise of stock options, net of withholding taxes paid related to common stock issued to employees, and warrants	270	749
Repurchase of common stock	(32)	(297)
Net cash provided by financing activities	118,542	25,715
Net increase (decrease) in cash and cash equivalents	25,415	(67,306)
Cash and cash equivalents at beginning of period	78,376	176,523
Cash and cash equivalents at end of period	103,791	109,217
Supplemental Disclosure
Cash paid for taxes	64	52
Cash paid for interest	4,803	3,285
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Purchase of property and equipment in accounts payable and accrued liabilities	91	102
Conversion of contingently redeemable convertible common stock and preferred stock to common stock	516,365	0
Assumption of derivative liabilities upon Business Combination	93,196	0
Reclassification of Grove's preferred stock warrant liability to equity	2,182	0
Net exercise of preferred stock warrants	989	0
Settlement of Additional Shares liability	16,310	0
Transaction costs and convertible preferred stock included in accounts payable and accrued liabilities	18,799	1,198
Vesting of early exercised stock options	125	1,413
Initial measurement of common stock warrants recorded as debt fees	$ 0	$ 1,622

Description of Business

Description of Business	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	Description of Business Grove Collaborative Holdings, Inc., a public benefit corporation, (formerly known as Virgin Group Acquisition Corp. II) and its wholly owned subsidiaries (collectively, the “Company” or “Grove”) is a digital-first, sustainability-oriented consumer products innovator specializing in the development and sale of household, personal care, beauty and other consumer products with an environmental focus and headquartered in San Francisco, California. In the United States, the Company sells its products through two channels: a direct-to-consumer (“DTC”) platform at www.grove.co and the Company’s mobile applications, where the Company sells products from Grove-owned brands (“Grove Brands”) and third-parties, and the retail channel into which the Company sell products from Grove-owned brands at wholesale. The Company develops and sells natural products that are free from the harmful chemicals identified in the Company’s “anti-ingredient” list and designs form factors and product packaging that reduces plastic waste and improves the environmental impact of the categories in which the Company operates. The Company also purchases environmental offsets that have made it the first plastic neutral retailer in the world, and we plan to become 100% plastic-free by 2025. Grove Collaborative, Inc. (herein referred to as “Legacy Grove”), the Company’s accounting predecessor, was incorporated in Delaware in 2016. On June 16, 2022 (the “Closing Date”), the Company consummated the previously-announced transactions contemplated by the Agreement and Plan of Merger, dated December 7, 2021, amended and restated on March 31, 2022 (the “Merger Agreement”), among Virgin Group Acquisition Corp. II, a blank check company incorporated as a Cayman Islands exempt company in 2020 (“VGAC II”), Treehouse Merger Sub, Inc. (“VGAC II Merger Sub I”), Treehouse Merger Sub II, LLC (“VGAC II Merger Sub II”), and Legacy Grove (“the Merger”). In connection with the Merger, VGAC II changed its jurisdiction of incorporation from the Cayman Islands to the State of Delaware and changed its name to Grove Collaborative Holdings, Inc (the “Domestication”), a public benefit corporation. On the Closing Date, VGAC Merger Sub II merged with and into Legacy Grove with Legacy Grove being the surviving corporation and a wholly-owned subsidiary of the Company (the “Initial Merger”), and, immediately following the Initial Merger, and as part of the same overall transaction as the Initial Merger, Legacy Grove merged with and into VGAC Merger Sub II, the separate corporate existence of Legacy Grove ceased, and Merger Sub II continued as the surviving company and a wholly-owned subsidiary of the Company and changed its name to Grove Collaborative, Inc.(together with the Merger and the Domestication, the “Business Combination”). The Business Combination is accounted for as a reverse recapitalization with Legacy Grove being the accounting acquirer and VGAC II as the acquired company for accounting purposes. Accordingly, all historical financial information presented in the unaudited condensed consolidated financial statements represents the accounts of Legacy Grove. The shares and net loss per common share prior to the Closing have been retroactively restated as shares reflecting the exchange ratio established in the Closing. Prior to the Business Combination, VGAC II’s public shares, and public warrants were listed on the New York Stock Exchange (“NYSE”) under the symbols “VGII” and “VGII.WS,” respectively. On June 17, 2022, the Company's Class A common stock and public warrants began trading on (“NYSE”), under the symbols “GROV” and “GROV.WS,” respectively. See Note 3, Recapitalization

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation and Liquidity The Company’s unaudited condensed consolidated financial statements (the “condensed consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiary in which it holds controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation. These condensed consolidated financial statements have been prepared in accordance with GAAP applicable to interim financial statements. These financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. As such, the information included herein should be read in conjunction with Legacy Grove’s financial statements and accompanying notes as of and for the year ended December 31, 2021 (the “audited financial statements”) that were included in the Company’s Proxy Statement/Prospectus filed with the SEC on May 17, 2021. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of September 30, 2022 and the results of operations for the three and nine months ended September 30, 2022 and 2021. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the full year ending December 31, 2022 or any other future interim or annual period. The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liabilities and commitments in the normal course of business. The Company has historically incurred losses and negative cash flows from operations and had an accumulated deficit of $565.2 million as of September 30, 2022. The Company’s existing sources of liquidity as of September 30, 2022 include cash and cash equivalents of $103.8 million. Prior to the Business Combination, the Company historically funded operations primarily with issuances of convertible preferred stock and contingently redeemable convertible common stock and the incurrence of debt. Upon the Closing of the Business Combination, the Company received $72.6 million in cash proceeds, net of transaction costs. The Company believes the Business Combination eliminated the substantial doubt about the Company’s ability to continue as a going concern from at least one year after the date of issuance of this quarterly report on Form 10-Q (the “Quarterly Report”). Over the longer-term, the Company will need to raise additional capital through debt or equity financing to fund future operations until it generates positive cash flows from profitable operations. There can be no assurance that such additional debt or equity financing will be available on terms acceptable to the Company, or at all. Emerging Growth Company The Company is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. The JOBS Act permits companies with emerging growth company status to take advantage of an extended transition period to comply with new or revised accounting standards, delaying the adoption of these accounting standards until they would apply to private companies. Following the closing of the Business Combination, the Company uses this extended transition period to enable it to comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date the Company (1) is no longer an emerging growth company or (2) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the Company’s condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting standards as of public company effective dates. Comprehensive Loss Comprehensive loss represents all changes in stockholders’ deficit. The Company’s net income (loss) was equal to its comprehensive loss for all periods presented. Significant Accounting Policies Except for the addition of the Business Combination and related derivative liabilities, there have been no significant changes in the Company's significant accounting policies from those that were disclosed in Note 2, Summary of Significant Accounting Policies, included in the Company’s audited financial statements and the notes thereto for the year ended December 31, 2021. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. These estimates made by management include the determination of reserves amounts for the Company’s inventories on hand, useful life of intangible assets, sales returns and allowances and certain assumptions used in the valuation of equity awards, the estimated fair value of common stock liability classified Public and Private Placement Warrants, the fair value of Earn-Out liabilities, and stock-based compensation expense. Actual results could differ from those estimates, and such estimates could be material to the Company’s financial position and the results of operations. The novel coronavirus (“COVID-19”) pandemic has created significant global economic uncertainty and resulted in the slowdown of economic activity. As of the date of issuance of these condensed consolidated financial statements, the extent to which COVID-19 may impact the future financial condition or results of operations is still uncertain. The Company is not aware of any specific event or circumstance that would require revisions to estimates, updates to judgments, or adjustments to the carrying value of assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the condensed consolidated financial statements. Concentration of Risks Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company maintains the majority of its cash and cash equivalents in accounts with one financial institution within the United States, generally in the form of demand accounts. Deposits in this institution may exceed federally insured limits. Management believes minimal credit risk exists with respect to this financial institution and the Company has not experienced any losses on such amounts. The Company depends on a limited number of vendors to supply products sold by the Company. For the three and nine months ended September 30, 2022 and 2021, the Company’s top five suppliers combined represented approximately 50% of the Company’s total inventory purchases. Revenue Recognition The Company primarily generates revenue from the sale of both third-party and Grove Brands products through its DTC platform. Customers purchase products through the website or mobile application through a combination of directly selecting items from the catalog, items that are suggested by the Company’s recurring shipment recommendation engine, and features that appear in marketing on-site, in emails and on the Company’s mobile application. Most customers purchase a combination of products recommended by the Company based on previous purchases and new products discovered through marketing or catalog browsing. Customers can have orders auto-shipped to them on a specified date or shipped immediately through an option available on the website and mobile application. In order to reduce the environmental impact of each shipment, the Company has a minimum total sales order value threshold policy which is required to be met before the order qualifies for shipment. Payment is collected upon finalizing the order. The products are subsequently packaged and shipped to fill the order. Customers can customize future purchases by selecting products they want to receive on a specified cadence or by selecting products for immediate shipment. The Company also offers a VIP membership to its customers for an annual fee which includes the rights to free shipping, free gifts and early access to exclusive sales, all of which are available at the customers’ option, should they elect to make future purchases of the Company’s products within their annual VIP membership benefit period. Many customers receive a free 60-day VIP membership for trial purposes, typically upon their first qualifying order. After the expiration of this free trial VIP membership period, customers will be charged their annual VIP membership fee, which automatically renews annually, until cancelled. The customer is alerted before any VIP membership renews. In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods, in an amount that reflects the consideration that it expects to receive in exchange for those goods. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration, if any, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods it transfers to a customer. A contract with a customer exists when the customer submits an order online for the Company’s products. Under this arrangement, there is one performance obligation which is the obligation for the Company to fulfill the order. Product revenue is recognized when control of the goods is transferred to the customer, which occurs upon the Company’s delivery to a third-party carrier. The VIP membership provides customers with a suite of benefits that are only accessible to them at their option, upon making a future qualifying order of the Company’s products. The VIP membership includes free shipping, a select number of free products and early access to exclusive sales. Under ASC 606, sales arrangements that include rights to additional goods or services that are exercisable at a customer’s discretion are generally considered options; therefore, the Company must assess whether these options provide a material right to the customer and if so, they are considered a performance obligation. The Company concluded that its VIP membership benefits include two material rights, one related to the future discount (i.e., free shipping) on the price of the customer’s qualifying order(s) over the membership period and the second one relating to a certain number of free products provided at pre-set intervals within the VIP membership benefit period, that will only ship with a customer’s next qualifying order (i.e., bundled). At inception of the VIP membership benefit period, the Company allocates the VIP membership fee to each of the two material rights using a relative standalone selling price basis. Generally, standalone selling prices are determined based on the observable price of the good or service when sold separately to non-VIP customers and the estimated number of shipments and free products per benefit period. The Company also considers the likelihood of redemption when determining the standalone selling price for free products and then recognize these allocated amounts upon the shipment of a qualifying customer order. To date, customers buying patterns closely approximate a ratable revenue attribution method over the customers VIP Membership period. The Company deducts discounts, sales tax, customer service credits and estimated refunds to arrive at net revenue. Sales tax collected from customers is not considered revenue and is included in accrued liabilities until remitted to the taxing authorities. The Company has made the policy election to account for shipping and handling as activities to fulfill the promise to transfer the good. Shipping, handling and packaging expenses are recognized upon shipment and classified within selling, general and administrative expenses. Discounts are recorded as a reduction to revenue when r evenue is recognized. The C ompany records a refund reserve based on historical refund patterns. As of September 30, 2022 an d December 31, 2021 the refund reserve, which is included in accrued liabilities in the condensed consolidated balance sheets, was $0.1 million. Disaggregation of Revenue The following table sets forth revenue by product type (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Revenue, net: Grove Brands $ 36,425 $ 45,762 $ 121,489 $ 145,516 Third-party products 41,308 49,416 126,002 150,905 Total revenue, net $ 77,733 $ 95,178 $ 247,491 $ 296,421 Contractual Liabilities The Company has three types of contractual liabilities from transactions with customers: (i) cash collections for products which have not yet shipped, which are included in deferred revenue and are recognized as revenue upon the Company’s delivery to a third-party carrier, (ii) cash collections of VIP membership fees, which are included in deferred revenue and (iii) customer service credits, which are included in other current liabilities and are recognized as a reduction in revenue when provided to the customer. Contractual liabilities included in deferred revenue and other current liabilities were $10.8 million and $0.3 million, respectively, as of September 30, 2022 and $11.3 million and $0.3 million, respectively, as of December 31, 2021. The contractual liabilities included in deferred revenue are generally recognized as revenue within twelve months from the end of each reporting period. Revenue recognized during the nine months ended September 30, 2022 that was previously included in deferred revenue and other current liabilities as of December 31, 2021 was $10.9 million and $0.2 million, respectively. Customer Referral Credits The Company has a customer referral program under which credits are issued for future purchases to customers when the referral results in the generation of a new customer order. The Company records a liability at the time of issuing the credit and reduce the liability upon application of the credit to a customer’s purchase. The liability for customer referral credits was $0.1 million as of September 30, 2022 and December 31, 2021 and is included within other current liabilities in the condensed consolidated balance sheets. Fulfillment Costs Fulfillment costs represent those costs incurred in operating and staffing the Company’s fulfillment centers, including costs attributable to receiving, inspecting and warehousing inventories, picking, packaging, and preparing customer orders for shipment (“Fulfillment Labor”), shipping and handling expenses, packaging materials costs and payment processing and related transaction costs. These costs are included within selling, general and administrative expenses in the condensed consolidated statements of operations. For the three months ended September 30, 2022 and 2021, the Company recorded fulfillment costs of $19.5 million and $23.5 million, respectively, which included $12.3 million and $14.3 million in shipping and handling expenses, respectively, and $4.3 million and $5.7 million in Fulfillment Labor, respectively. For the nine months ended September 30, 2022 and 2021 , the Company recorded fulfillment costs of $64.2 million and $72.5 million, respectively, which included $39.4 million and $43.2 million in shipping and handling expenses, respectively, and $15.4 million and $17.8 million in Fulfillment Labor, respectively. The Company's gross profit may not be comparable to other retailers or distributors. Warrant Liabilities The Company classifies Private Placement Warrants and Public Warrants (both defined and discussed in Note 9, Common Stock and Warrants) as liabilities. At the end of each reporting period, changes in fair value during the period are recognized within the condensed consolidated statements of operations. The Company will continue to adjust the warrant liability for changes in the fair value until the earlier of a) the exercise or expiration of the warrants or b) the redemption of the warrants, at which time the warrants will be reclassified to additional paid-in capital.

Recapitalization

Recapitalization	9 Months Ended
	Sep. 30, 2022
Reverse Recapitalization [Abstract]
Recapitalization	Recapitalization As discussed in Note 1, Description of Business, on the Closing Date, VGAC II completed the acquisition of Legacy Grove and acquired 100% of Legacy Grove’s shares and Legacy Grove received gross proceeds of $97.1 million, which includes proceeds from issuance of common stock upon the consummation of the Business Combination, including the Backstop Tranche 2 shares, and proceeds from the PIPE investment (as defined below). The Company recorded $24.5 million of transaction costs, which consisted of legal, accounting, and other professional services directly related to the Business Combination. Transaction costs were allocated on a relative fair value basis between the issuance of common stock, Public and Private Placement Warrants, Grove Earn-Out Shares, Downside Protection feature and Backstop Warrants (as defined below). Direct and incremental transaction costs allocated to equity-classified instruments have been recorded within equity as an offset against proceeds upon accounting for the consummation of the Business Combination in the condensed consolidated financial statements. Direct and incremental transaction costs allocated to liability-classified equity instruments were expensed in the condensed consolidated financial statements and included in other expense, net in the condensed consolidated statements of operations . The cash outflows related to these costs were presented as financing activities on the Company’s condensed consolidated statement of cash flows. On the Closing Date, each holder of Legacy Grove common stock received approximately 1.1760 shares of the Company’s Class B common stock, par value $0.0001 per share. See Note 8, Convertible Preferred Stock and Note 9, Common Stock and Warrants for additional details of the Company's equity balances prior to and subsequent to the Business Combination. All equity awards of Legacy Grove were assumed by the Company and converted into comparable equity awards that are settled or exercisable for shares of the Company’s Class B common stock. As a result, each outstanding stock option was converted into an option exercisable for the Company’s Class B common stock based on an exchange ratio of approximately 1.1760, each outstanding restricted stock unit was converted into restricted stock units of the Company that, upon vesting and issued, will be settled for shares of the Company’s Class B common stock based on an exchange ratio of approximately 1.1760 and each outstanding warrant to purchase Legacy Grove common stock or preferred stock was converted into a warrant to purchase shares of the Company’s Class B common stock based on an exchange ratio of approximately 1.1760. Each public and private warrant of VGAC II that was unexercised at the time of the business combination was assumed by the Company and represents the right to purchase one share of the Company’s Class A common stock upon exercise of such warrant. The Merger was accounted for as a reverse recapitalization with Legacy Grove as the accounting acquirer and VGAC II as the acquired company for accounting purposes. Legacy Grove was determined to be the accounting acquirer since Legacy Grove’s shareholders prior to the business combination had the greatest voting interest in the combined entity, Legacy Grove's shareholders appointed the initial directors of the combined Board of Directors and control future appointments, Legacy Grove comprises all of the ongoing operations, and Legacy Grove's senior management directs operations of the combined entity. Accordingly, all historical financial information presented in these condensed consolidated financial statements represents the accounts of Legacy Grove. Net assets were stated at historical cost consistent with the treatment of the transaction as a reverse recapitalization of Legacy Grove. Earn-Out At the closing of the Business Combination, Class B common stock shareholders (including Grove stock option, restricted stock unit, and warrant holders) were issued 13,999,960 shares of New Grove Class B Common Stock (“Earn-Out Shares”), which will vest (i) with respect to 7,000,173 of the Earn-Out Shares, upon the closing price of the Company’s Class A common stock equaling or exceeding $12.50 per share for any 20 trading days within any 30-trading-day period and (ii) with respect to 6,999,787 of the Earn-Out Shares, upon the closing price of the Company’s Class A common stock equaling or exceeding $15.00 per share for any 20 trading days within any 30-trading-day period. Such events can occur during a period of ten years following the Mergers (the “Earn-Out Period”). If, during the Earn-Out Period, there is a Change of Control Transaction (as defined in the Merger Agreement), then all remaining triggering events that have not previously occurred and the related vesting conditions shall be deemed to have occurred. If, upon the expiration of the Earn-Out Period, any Earn-Out Shares shall have not vested, then such Earn-Out Shares shall be automatically forfeited by the holders thereof and canceled by the Company. The settlement amount to be paid to the selling shareholders of the Earn-Out Shares can change and is not indexed to the Company’s stock. Due to the change in control event contingency and variable number of Earn-Out shares to be settled to the holders, the Earn-Out Shares fail the equity scope exception and are accounted for as a derivative in accordance with ASC 815 and it will be remeasured on a recurring basis at fair value, with changes in fair value recorded in the condensed consolidated statements of operations. As of September 30, 2022, the Company did not meet any Earn-Out thresholds. PIPE Investmen t On December 7, 2021, concurrently with the execution of the Merger Agreement , VGAC II entered into subscription agreements with certain investors (the “PIPE Investors”) to which such investors collectively subscribed for an aggregate of 8,707,500 shares of the Company’s Class A common stock at $10.00 per share for aggregate gross proceeds of $87,075,000 (the “PIPE Investment”). 8,607,500 shares of the Company’s Class A common stock have been issued for aggregate proceeds of $86,075,000, which consummated concurrently with the closing to the Business Combination. Backstop Financing On March 31, 2022, VGAC II entered into a subscription agreement (the “Backstop Subscription Agreement”) with Corvina Holdings Limited (the “Backstop Investor”) and Legacy Grove. As part of the Backstop Subscription Agreement, the Backstop Investor subscribed for and purchased 2,338,352 shares of Legacy Grove Common Stock (the “Backstop Tranche 1 Shares”) for aggregate proceeds of $27,500,000. The Company initially classified the Backstop Tranche 1 Shares as mezzanine (or temporary) equity on its balance sheet because the Backstop Tranche 1 Shares were contingently redeemable upon the occurrence of certain events not solely within the control of the Company that allow for the effective redemption of such shares in cash at the option of the holder. Upon Closing of the Business Combination, the Backstop Tranche 1 Shares were converted into 2,750,000 shares of Class A Common Stock and the Tranche 1 Shares were no longer contingently redeemable. The Company has classified these shares in permanent equity on its balance sheet at September 30, 2022. In addition, the Backstop Investor agreed to subscribe for and purchase, on the closing date of the Business Combination, certain shares of New Grove class A common stock at a purchase price of $10.00 per share (“Backstop Tranche 2 Shares”) for aggregate gross proceeds in an amount equal to (x) $22.5 million minus (y) the amount of aggregate cash remaining in VGAC II’s trust account, after deducting any amounts paid to VGAC II shareholders who exercise their redemption rights in connection with the Business Combination. The Company issued to the Backstop Investor, as of immediately following the closing of the Mergers, 1,671,524 Backstop Tranche 2 Shares for aggregate proceeds of $16,715,240. The Backstop Subscription Agreement also provided that the Company would issue additional shares of Class A common stock to the Backstop Investor for Backstop Tranche 1 Shares and Backstop Tranche 2 Shares if the volume weighted average price of Class A common stock was less than $10.00 during the 10 trading days commencing on the first trading date after the Company’s first quarterly earnings call for the fiscal quarter ended June 30, 2022 (“Additional Shares”). In August 2022, the Company settled this obligation by issuing 3,275,182 shares of Class A common stock to the Backstop Investor. As part of the Backstop Subscription Agreement, the Company issued to the Backstop Investor 3,875,028 warrants to purchase New Grove Class A Common Stock (each warrant exercisable to purchase one share of New Grove Class A Common Stock for $0.01) (such warrants, the “Backstop Warrants”). The Backstop Warrants are exercisable by the Backstop Investor at any time on or before June 16, 2027, and are on terms customary for warrants of such nature. The Backstop Warrants were recorded in equity on the Company’s balance sheet at September 30, 2022.

Fair Value Measurements and Fai

Fair Value Measurements and Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements and Fair Value of Financial Instruments	Fair Value Measurements and Fair Value of Financial Instruments The Company measures certain financial assets and liabilities at fair value on a recurring basis. The Company determines fair value based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. These levels are: Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; Level 2 – Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and Level 3 – Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data. Financial instruments consist of cash equivalents, accounts payable, accrued liabilities, debt and convertible preferred stock warrant liability, Additional Shares, Earn-Out Shares and Public and Private Placement Warrants. Cash equivalents, convertible preferred stock warrant liability, Earn-Out Shares and Public and Private Placement Warrant are stated at fair value on a recurring basis. Accounts payable and accrued liabilities are stated at their carrying value, which approximates fair value due to the short period time to the expected receipt or payment. The carrying amount of the Company’s outstanding debt approximates the fair value as the debt bears interest at a rate that approximates prevailing market rate. The Public Warrants are classified as Level 1 due to the use of an observable market quote in an active market. Private Placement Warrants are classified as Level 2 as the fair value approximates the fair value of the Public Warrants. The Private Placement Warrants are identical to the Public Warrants, with certain exception discussed in Note 9, Common Stock and Warrants. The Earn-Out Shares are classified as Level 3 and their fair values were estimated using a Monte Carlo options pricing model utilizing assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimated the expected volatility assumption based on the implied common stock volatilities of a set of publicly traded peer companies. Changes in this assumption, including the selection of or quantities of companies with the peer company set, could materially affect the estimate of the fair value of these instruments and the related change in fair value of these instruments. The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis as of September 30, 2022 and December 31, 2021 by level within the fair value hierarchy (in thousands): September 30, 2022 Level 1 Level 2 Level 3 Total Financial Assets: Cash equivalents: Money market funds $ 102,094 $ — $ — $ 102,094 Total $ 102,094 $ — $ — $ 102,094 Financial Liabilities: Earn-Out Shares — — 24,345 24,345 Public Warrants 1,851 — — 1,851 Private Placement Warrants — 1,541 — 1,541 Total $ 1,851 $ 1,541 $ 24,345 $ 27,737 December 31, 2021 Level 1 Level 2 Level 3 Total Financial Assets: Cash equivalents: Money market funds $ 77,771 $ — $ — $ 77,771 Total $ 77,771 $ — $ — $ 77,771 Financial Liabilities: Convertible preferred stock warrant liability $ — $ — $ 4,787 $ 4,787 Total $ — $ — $ 4,787 $ 4,787 There were no transfers of financial assets or liabilities into or out of Level 1, Level 2, or Level 3 during the periods presented. Additional Shares At closing of the Mergers, the Company recorded a liability of $15.3 million related to the potential issuance of the Additional Shares related to the Backstop Subscription Agreement. Subsequent changes in fair value of the Additional Shares liability until settlement is recognized in the statements of operations. The following table provides a summary of changes in the estimated fair value of the Additional Shares liability (in thousands): Balance at December 31, 2021 $ — Assumption of Additional Shares liability 15,340 Change in fair value 970 Settlement of Additional Shares liability (16,310) Balance at September 30, 2022 $ — Earn-Out Shares At Closing of the Mergers, certain Earn-Out Shares were accounted for as a liability totaling $70.5 million. Subsequent changes in fair value, until settlement or until equity classification is met, is recognized in the statements of operations. The following table provides a summary of changes in the estimated fair value of the Earn-Out liability (in thousands): Balance at December 31, 2021 $ — Assumption of Earn-Out liability 70,481 Change in fair value (46,136) Balance at September 30, 2022 $ 24,345 Private Placement and Public Warrant Liabilities As of September 30, 2022, the Company has Private Placement and Public Warrants defined and discussed in Note 9, Common Stock and Warrants. Such warrants are measured at fair value on a recurring basis. The following table provides a summary of changes in the estimated fair value of the Private Placement Warrants and Public Warrants (in thousands): Private Placement Warrants Public Warrants Balance at December 31, 2021 $ — $ — Assumption of Private Placement and Public Warrants 3,350 4,025 Changes in fair value (1,809) (2,174) Balance at September 30, 2022 $ 1,541 $ 1,851 Convertible Preferred Stock Warrant Liability The fair value of the preferred stock warrant liability is determined using the Black-Scholes option pricing model, which involve inherent uncertainties and the application of management’s judgment. The following table provides a summary of changes in the estimated fair value of the preferred stock warrant liability (in thousands): Balance at December 31, 2021 $ 4,787 Change in fair value (1,616) Net exercise of preferred stock warrants (989) Balance before reclassification immediately prior to the Business Combination 2,182 Reclassification to additional paid-in capital (2,182) Balance at September 30, 2022 $ — The Company recorded a gain of $1.6 million and a loss of $1.5 million on remeasurement of preferred stock warrant liability for the nine months ended September 30, 2022 and 2021, respectively. With the closing of the Business Combination, unexercised preferred stock warrants were converted into warrants of the Company to purchase shares of common stock and the preferred stock warrant liability is reclassified to additional paid-in capital.

Accrued Expenses

Accrued Expenses	9 Months Ended
	Sep. 30, 2022
Payables and Accruals [Abstract]
Accrued Expenses	Accrued Expenses Accrued expenses consisted of the following (in thousands): September 30, December 31, Inventory purchases $ 2,685 $ 4,659 Compensation and benefits 2,944 2,072 Advertising costs 1,058 2,363 Fulfillment costs 2,209 1,120 Sales taxes 1,544 1,812 Transaction costs 18,764 1,846 Other accrued expenses 6,605 6,779 Total accrued expenses $ 35,809 $ 20,651

Debt

Debt	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Debt	Debt The Company’s outstanding debt, net of debt discounts, consisted of the following (in thousands): September 30, December 31, Silicon Valley Bank Loan Revolver $ 5,947 $ 5,947 Silicon Valley Bank and Hercules Mezzanine Term Loan 59,383 59,237 Atel Loan Facility Draw 3 751 1,489 Atel Loan Facility Draw 4 139 260 Total debt 66,220 66,933 Less: debt, current (28,447) (10,750) Total debt, noncurrent $ 37,773 $ 56,183 Silicon Valley Bank Loan Facility In December 2016, the Company entered into a loan and security agreement (the “SVB Loan Facility”) with Silicon Valley Bank (“SVB”). The terms of the SVB Loan Facility, as amended and restated, provided for: (i) a revolving line of credit not to exceed $25.0 million (“Loan Revolver”), (ii) growth capital advance (“Term Loan”) of $3.9 million and (iii) a letter of credit sublimit of $6.0 million. The Term Loan had a maturity date in December 2022 and bore interest at Prime Rate per annum, payable monthly. The Loan Revolver borrowing capacity was limited to 60% of eligible inventory balances. In April 2021, the Company entered into an amendment to the SVB Loan Facility, which incurs a facility fee of 0.20% per annum assessed on the daily average undrawn portion of revolving line of credit. In addition, the Loan Revolver letter of credit sublimit increased to $10.0 million and t he Loan Revolver borrowing capacity increased to 65% of eligible inventory balances. The Loan Revolver borrowing capacity is reduced by outstanding letters of credit and credit available to the Company from certain credit card facilities, which amounted to $3.1 million and $1.5 million, respectively as of September 30, 2022. The amended Loan Revolver bears an interest rate equal to the greater of prime rate or 3.25% per annum and matures on March 31, 2023. Interest on the Loan Revolver is payable monthly in arrears. In April 2021, all of the Company’s outstanding amounts under the SVB Term Loan were refinanced directly through the SVB and Hercules Loan Facility (see below). The Company determined the refinance represented an extinguishment of the SVB Term Loan and recorded a loss on extinguishment of $1.0 million during the three months ended June 30, 2021. The SVB Loan Facility is collateralized by substantially all of the Company’s assets on a first priority basis and contains customary events of default. The SVB Loan Facility includes affirmative, negative, and financial covenants that restrict the Company’s ability to, among other things, incur additional indebtedness, other than permitted indebtedness, enter into mergers or acquisitions, sell or otherwise dispose of assets, pay dividends, or repurchase stock, subject to customary exceptions. The SVB Loan Facility contains certain financial covenants which requires the Company to maintain minimum liquidity of $45.0 million. Minimum liquidity is defined as the sum of the aggregate amount of unrestricted and unencumbered cash deposited with SVB plus amounts available to be drawn under the loan revolver, as adjusted for any outstanding standby letters of credit issued by SVB. As of September 30, 2022, the Company was in compliance with all covenants and had $5.9 million outstanding under the revolving line of credit, with an effective interest rate of 5.60%. Silicon Valley Bank and Hercules Loan Facility In April 2021, the Company entered into a Mezzanine Loan and Security Agreement (“SVB and Hercules Loan Facility”) with SVB and Hercules Capital, Inc. (“Hercules”). The availability period ran from the effective date until June 30, 2022, provides for advances of up to $60.0 million. In April 2021, the Company drew $25.0 million, which it used to directly settle the amounts outstanding under the SVB Term Loan. In September and December 2021, the Company drew down the remaining additional borrowings of $25.0 million and $10.0 million, respectively . The SVB and Hercules Loan Facility bears an annual interest at the greater of 8.75% or prime plus 5.5%, payable monthly. The principal repayment period commences on November 1, 2022 and continues for 30 monthly installments with an additional final payment equal to 6.75% of the aggregate term loan advances. SVB and Hercules have committed to fund 51.0% and 49.0%, respectively, of all draws made under the SVB and Hercules Loan Facility. In May 2022, as part of the Closing of the Business Combination, the Company entered into an amendment with SVB and Hercules Loan Facility which increased the final payment from 6.75% to 8.75% of the aggregate term loan advances. The SVB and Hercules Loan Facility is collateralized on a second priority basis, subordinate to the SVB Loan Facility, by substantially all of the Company’s assets and contains affirmative and negative covenants that restrict the Company’s ability to, among other things, incur additional indebtedness, other than permitted indebtedness, enter into mergers or acquisitions, sell or otherwise dispose of assets, pay dividends or repurchase stock, subject to customary exceptions. The SVB and Hercules Loan Facility does not include any financial covenants, but does contain a subjective acceleration clause in the event that lenders determine that a material adverse change has or will occur within the business, operations, or financial condition of the Company or a material impairment of the prospect of repaying any portion of this financial obligation. In accordance with the loan agreement, SVB and Hercules have been provided with the Company’s periodic financial statements and updated projections to facilitate their ongoing assessment of the Company. The Company believes the likelihood that SVB and Hercules would exercise the subjective acceleration clause is remote. As of September 30, 2022, the Company had an aggregate of $60.0 million outstanding under the SVB and Hercules Loan Facility, excluding unamortized debt issuance cost, with effective interest rates ranging from 15.78% to 18.83%. As of September 30, 2022, the Company was in compliance with all covenants. Atel Loan Facility In July 2018, the Company entered into an equipment financing arrangement (the “Atel Loan Facility”) with Atel Ventures, Inc. (“Atel”) for funding of machinery and warehouse equipment that will become collateral. The loan agreement contains customary events of default. As of September 30, 2022, the Company had $0.8 million outstanding on its third draw and $0.1 million outstanding on its fourth draw, which mature in April 2023 and May 2023, respectively. The effective interest rates on the loans are 19.23%. By the end of the equal monthly installments of principal and interest, the principal under each loan will be fully repaid.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Merchandise Purchase Commitments As of September 30, 2022 and December 31, 2021 , the Company had obligations to purchase $17.9 million and $36.1 million, respectively, of merchandise. Letters of Credit The Company had irrevocable standby letters of credit in the amount of $3.1 million as of September 30, 2022 and December 31, 2021 related to the Company’s operating leases. The letters of credit have expiration dates through January 2029. Contingencies The Company records loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company also discloses material contingencies when a loss is not probable but reasonably possible. Accounting for contingencies requires the Company to use judgment related to both the likelihood of a loss and the estimate of the amount or range of loss. Although the Company cannot predict with assurance the outcome of any litigation or non-income-based tax matters, the Company does not believe there are currently any such actions that, if resolved unfavorably, would have a material impact on the Company’s financial position, operating results or cash flows.

Convertible Preferred Stock

Convertible Preferred Stock	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Convertible Preferred Stock	Convertible Preferred Stock The Company’s outstanding convertible preferred stock consisted of the following as of December 31, 2021 (in thousands, except share and per share data): Original Issue Price Shares Authorized Shares Outstanding Net Carrying Value Liquidation Preference Series Seed $ 0.5245 9,693,116 9,693,115 $ 3,943 $ 5,084 Series A 0.5245 14,130,360 14,069,657 5,240 7,379 Series B 1.2450 12,689,363 12,563,418 15,545 15,642 Series C 2.4144 15,635,550 15,324,913 36,917 37,000 Series C-1 3.1669 8,554,106 8,554,106 27,003 27,090 Series D 7.0135 20,196,682 19,961,423 136,618 140,000 Series D-1 9.0731 5,314,209 5,314,209 48,146 48,216 Series D-2 6.1850 14,551,371 14,551,370 89,638 90,000 Series E 8.4672 14,762,823 14,762,823 124,868 125,000 Total 115,527,580 114,795,034 $ 487,918 $ 495,411 Conversion At the closing of the Business Combination, all series of convertible preferred stock of Legacy Grove were converted on an as-converted basis to the Company’s Class B common stock at an exchange ratio of approximately 1.1760. As of September 30, 2022, no shares of convertible preferred stock were outstanding.

Common Stock and Warrants

Common Stock and Warrants	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Common Stock and Warrants	Common Stock and Warrants Prior to the Business Combination, Legacy Grove had one class of authorized common stock (Class B common stock). The outstanding shares of Legacy Grove common stock is presented on the consolidated balance sheet and on the statements of convertible preferred stock, contingently redeemable convertible common stock and stockholders’ deficit for the year ended December 31, 2021. Merger Transaction On the Closing Date and in accordance with the terms and subject to the conditions of the Business Combination, each common stock, par value $0.0001 per share (other than Backstop Tranche 1 Shares), preferred stock, outstanding options (whether vested or unvested), restricted stock units (whether vested or unvested) and warrants of Legacy Grove was canceled and converted into a comparable number of awards (i) that consisted of either the rights to receive or acquire shares of the Company’s Class B common stock, par value $0.0001 per share, as determined by the exchange ratio, and (ii) the right to receive a number of the Company’s Earn-Out shares. Each Backstop Tranche 1 Shares issued to the Backstop Investor pursuant to the Backstop Subscription Agreement was canceled and converted into the right to receive a number of shares of the Company’s Class B common stock equal to the exchange ratio, which were immediately exchanged on a one-for-one basis for shares of the Company’s Class A common stock). The exchange ratio is approximately 1.1760. On June 16, 2022, in connection with the closing of the Business Combination, the Company amended and restated its certificate of incorporation to authorize 900,000,000 shares, consisting of (a) 800,000,000 shares of common stock, including (i) 600,000,000 shares of Class A common stock, and (ii) 200,000,000 shares of Class B common stock, and (b) 100,000,000 shares of preferred stock. The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to number of voting rights. Holders of Class A common stock are entitled to one vote per share and holders of Class B common stock are entitled to ten votes per share. Each share of Class B common stock is convertible into one share of Class A common stock any time at the option of the holder, and is automatically converted into one share of Class A common stock upon transfer (except for certain permitted transfers). Once converted into Class A common stock, the Class B common stock will not be reissued. The Company’s Board of Directors has the authority to issue shares of the Preferred Stock in one or more series and to determine the voting rights, designations, powers, preferences, other rights and restrictions of each such series of shares. As of September 30, 2022, no shares of preferred stock were issued and outstanding. Class A Common Stock Warrants As the accounting acquirer, Grove Collaborative, Inc. is deemed to have assume d 6,700,000 P rivate Placement Warrants for Class A common stock that were held by Virgin Group Acquisition Sponsor II LLC (the “Sponsor”) at an exercise price of $11.50 and 8,050,000 Class A common stock Public Warrants that were held by VGAC II’s shareholders at an exercise price of $11.50. The warrants will expire on July 16, 2027, or earlier upon redemption or liquidation. Subsequent to the Closing of the Business Combination, the Private Placement and Public Warrants for shares of Class A common stock meet liability classification requirements since the warrants may be required to be settled in cash under a tender offer. In addition, Private Placement warrants are potentially subject to a different settlement amount as a result of being held by the Sponsor which precludes the private placement warrants from being considered indexed to the entity's own stock. Therefore, these warrants are classified as liabilities on the condensed consolidated balance sheets and amounted to $3.4 million as of September 30, 2022. As of September 30, 2022, the following Warrants were outstanding: Warrant Type Shares Exercise Price Public Warrants 8,050,000 $ 11.50 Private Placement Warrants 6,700,000 $ 11.50 Public Warrants The Public Warrants become exercisable into shares of Class A common stock commencing on July 16, 2022 and expire on July 16, 2027, or earlier upon redemption or liquidation. At closing, the Company assumed 8,050,000 public warrants. Each warrant entitles the holder to purchase one share of the Company’s Class A common stock at a price of $11.50 per share, subject to certain adjustments. The Company may redeem, with 30 days written notice, each whole outstanding Public Warrant for cash at a price of $0.01 per warrant if the Reference Value equals or exceeds $18.00 per share, subject to certain adjustments. The warrant holders have the right to exercise their outstanding warrants prior to the scheduled redemption date during the Redemption Period at $11.50 per share, subject to certain adjustments. If the Company calls the Public Warrants for redemption, the Company will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis”, as described in the warrant agreement. For purposes of the redemption, “Reference Value” shall mean the last reported sales price of the Company’s Class A common stock for any twenty thirty Private Placement Warrants The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants are exercisable on a cashless basis and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, then such warrants will be redeemable by the Company and exercisable by the warrant holders on the same basis as the Public Warrants. At Closing, the Company assumed 6,700,000 Private Placement Warrants. Standby Equity Purchase Agreement On July 18, 2022, the Company entered into a Standby Equity Purchase Agreement (the “SEPA”) with YA II PN, LTD (“Yorkville” or “SEPA Investor”), pursuant to which Yorkville has agreed to purchase up to $100 million of common stock from time to time over a period of 36 months. The Company may, from time to time and at its sole discretion, direct the SEPA Investor to purchase Class A common stock in accordance with certain dollar thresholds as determined within the SEPA. The purchase price per share for Class A common stock will be 97.55% of the Volume-Weighted Average Price (“VWAP”) of the Company’s Class A common stock over the Pricing Period, as defined by the agreement. The Company deferred $0.7 million of transaction costs related to the SEPA and will offset these costs against proceeds of any sales under the SEPA. As of September 30, 2022, the Company has sold 40,833 shares under the SEPA for total gross proceeds of $0.1 million. As of September 30, 2022, there were 32,516,831 shares available to be sold to Yorkville under the SEPA. Reserved for Issuance The Company has the following shares of common stock reserved for future issuance, on an as-if converted basis: September 30, 2022 December 31, 2021 Class A Common Stock Class B Common Stock Class A Common Stock Class B Common Stock Convertible preferred stock — — — 115,287,015 Convertible preferred stock warrants — — — 735,760 Private Placement Warrants 6,700,000 — — — Public Warrants 8,050,000 — — — Backstop Warrants 3,875,028 — — — Common Stock Warrants — 900,147 — 688,349 Outstanding Stock Options 9,225,954 14,942,882 — 27,882,520 Outstanding Restricted Stock Units 4,252,388 1,045,063 — 1,777,183 Remaining Shares available for issuance under 2016 Equity Incentive Plan — — — 1,070,974 Remaining Shares available for issuance under 2022 Equity Incentive Plan 25,403,278 — — — Shares available for issuance under 2022 Employee Stock Purchase Plan 3,274,070 — — — Total shares of common stock reserved 60,780,718 16,888,092 — 147,441,801

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation Equity Incentive Plan In 2016, Legacy Grove adopted the 2016 Equity Incentive Plan (the “2016 Plan”). The Plan provides for the granting of stock-based awards to employees, directors and consultants under terms and provisions established by the Board of Directors. In April 2022, the Company’s Board of Directors authorized an increase in the number of shares available for issuance under the 2016 Plan by 3,500,000. In addition, all equity awards of Legacy Grove that were issued under the 2016 Plan were converted into comparable equity awards that are settled or exercisable for shares of the Company’s Class B common stock. As a result, each of Legacy Grove’s equity awards were converted into an option to purchase shares of the Company’s Class B common stock based on an exchange ratio of approximately 1.1760. As of the effective date of the 2022 Plan, no further stock awards have been or will be granted under the 2016 Plan. In June 2022, the stockholders of the Company approved the Grove Collaborative Holdings, Inc. 2022 Stock Incentive Plan (the “2022 Plan”). The Plan provides for the granting of stock-based awards to eligible participants, specifically officers, other employees, non-employee directors, consultants, independent contractors under terms and provisions established by the Board of Directors. The 2022 Plan authorizes the issuance of Class A common stock of up to 24,555,528. The number of shares available shall increase annually on the first day of each calendar year, beginning with calendar year ending December 31, 2023 and continuing until (and including) calendar year December 31 2032, with annual increases equal to lesser of (i) 5% of the number of shares of Class A and Class B common stock issued and outstanding on December 31 of the immediately preceding fiscal year, and (ii) an amount determined by the Board. Stock option activity under the 2016 Plan is as follows (in thousands, except share and per share amounts): Options Outstanding Number of Options Weighted–Average Exercise Price Weighted-Average Remaining Contractual Life (years) Aggregate Intrinsic Value Balance – December 31, 2021 23,708,957 $ 3.05 7.99 $ 125,429 Recapitalization 4,173,563 (0.46) Balance – December 31, 2021 27,882,520 2.59 7.99 125,429 Exercised (216,856) 1.61 Cancelled/forfeited (3,496,828) 3.30 Balance – September 30, 2022 24,168,836 2.50 6.67 12,319 Options vested and exercisable – September 30, 2022 16,796,373 $ 2.50 5.98 $ 11,863 The weighted-average grant date fair value of options granted during the nine months ended September 30, 2021 was $3.71 per share. No options were granted during the nine months ended September 30, 2022. The total grant date fair value of options that vested during the nine months ended September 30, 2022 and 2021 was $10.2 million and $9.4 million, respectively. The aggregate intrinsic value of options exercised during the nine months ended September 30, 2022 and 2021 was $1.0 million and $2.6 million, respectively. The aggregate intrinsic value is the difference between the current fair value of the underlying common stock and the exercise price for in-the-money stock options. Early Exercise of Employee Options The Company allows certain employees to exercise options granted under the Plan prior to vesting in exchange for shares of restricted common stock. The unvested shares, upon termination of employment, are subject to repurchase by the Company at the original purchase price. The proceeds are recorded in other current liabilities in the consolidated balance sheets at the time of the early exercise of stock options and reclassified to common stock and additional paid-in capital as the Company’s repurchase right lapses (i.e., as the underlying stock options vest). No and 11,025 shares of common stock were issued due to early exercise of unvested stock options during the nine months ended September 30, 2022 and 2021 . As of September 30, 2022 and December 31, 2021 , the aggregate price of the restricted common stock subject to repurchase was zero and $0.2 million, respectively. A summary of the restricted common stock is as follows: Number of Options Weighted–Average Exercise Price Outstanding and unvested as of December 31, 2021 69,513 $ 2.25 Recapitalization 12,237 (0.33) Outstanding and unvested as of December 31, 2021 81,750 1.92 Vested (65,211) 1.92 Repurchase of early exercise (16,539) 1.92 Outstanding and unvested as of September 30, 2022 — $ — Determination of Fair Value The fair value of stock option awards granted to employees was estimated at the date of grant using the Black-Scholes option-pricing model, with the following assumptions: Three Months Ended September 30, 2021 Nine Months Ended September 30, 2021 Fair value of common stock $6.91 $5.06 – $6.91 Expected term (in years) 5.64 – 6.10 5.00 – 6.28 Volatility 65.74% – 65.96% 62.33% – 75.19% Risk-free interest rate 0.81% – 0.88% 0.50% – 1.16% Dividend yield — — Market-Based Stock Options In February 2021, the Company granted 1,017,170 stock options with market and liquidity event-related performance-based vesting criteria with an exercise price of $3.77 per share. 100% of awards vest upon valuation of the Company’s stock at a stated price upon occurrence of specified transactions. Fair value was determined using the probability weighted expected term method (“PWERM”), which involves the estimation of future potential outcomes as well as values and probabilities associated with each potential outcome. Two potential scenarios were used in the PWERM that utilized 1) the value of the Company’s common equity, and 2) a Monte Carlo simulation to specifically value the award. The total grant date fair value of the award was determined to be $5.5 million. Since a liquidity event is not deemed probable until such event occurs, no compensation cost related to the performance condition was recognized prior to the Business Combination on June 16, 2022. Subsequently, the Company recorded stock-based compensation expense of $4.6 million for service periods completed prior to the Business Combination. As of September 30, 2022, the market-based vesting criteria had not been met. Performance-Based Restricted Stock Units Performance-based restricted stock units activity under the 2016 Plan is as follows: Number of shares Weighted–Average Grant Date Fair Value Per Share Unvested – December 31, 2021 1,511,191 $ 8.62 Recapitalization 265,992 (1.29) Unvested – December 31, 2021 1,777,183 7.33 Granted 4,748,063 5.93 Vested (1,244,537) 5.94 Cancelled/forfeited (1,227,795) 6.69 Balance – September 30, 2022 4,052,914 6.15 Vested but unissued – September 30, 2022 1,244,537 $ 5.94 RSUs granted under the 2016 Plan contain vesting conditions based on continuous service and the occurrence of a specified liquidity event, which is considered a performance condition. The performance condition is satisfied upon the consummation of (i) an initial underwritten public offering of the Company’s common stock; (ii) a change in control event, or (iii) a merger, consolidation or similar transaction in which the Company’s common stock outstanding immediately preceding such transaction are converted or exchanged into securities that are publicly-traded on an established exchange (the “Liquidity Event”), provided that the Liquidity Event occurs prior to the fifth anniversary of the grant date and the recipient continues to provide service to the Company on such date. The Company satisfied the performance condition on June 16, 2022 with the Closing of the Business Combination. Accordingly, the Company started recognizing stock compensation expense in the three months ended June 30, 2022 using the accelerated attribution method from the grant date. The total cumulative catch up expense related to prior periods recognized for the RSUs was $11.9 million. The vested but unissued RSUs will be issued to the common stockholders in November 2022 upon the termination of the Lock-Up Period, as defined in Section 7.10 of the Company’s Bylaws . There are no other contingencies for the issuance of these RSUs other than passage of time. Equity Award Modifications During the nine months ended September 30, 2022, the Company modified options held by former and existing employees to accelerate vesting and to extend the post termination exercise period of the awards from 60 days to 1, 2 or 10 years after termination, as well as accelerated the vesting of certain RSUs. The modifications resulted in modification expenses of $0.5 million and $2.2 million during the three and nine months ended September 30, 2022, respectively. On September 26, 2022, the Company’s Board of Directors approved a stock option exchange to permit certain employee and non-employee option holders, subject to specified conditions, to exchange some or all of their outstanding options to purchase shares of the Company's common stock for a lesser amount of RSUs to be issued under the 2022 Plan (the “Option Exchange”). The Option Exchange was completed in October 2022, see Note 12, Subsequent Events. Stock-Based Compensation Expense For the three months ended September 30, 2022 and 2021

Net income (Loss) Per Share Att

Net income (Loss) Per Share Attributable to Common Stockholders	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Net income (Loss) Per Share Attributable to Common Stockholders	Net income (Loss) Per Share Attributable to Common Stockholders The following table presents calculation of basic and diluted loss per share (in thousands, except share and per share data): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Net income (loss), basic and diluted $ 7,662 $ (37,498) $ (75,032) $ (103,909) Net income (loss) per share attributable to common stockholders, basic $ 0.05 $ (4.24) $ (1.13) $ (12.42) Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic 154,995,402 8,837,011 66,393,538 8,366,464 Effect of dilutive common stock options outstanding 10,234,953 — — — Effect of dilutive RSUs outstanding 554,947 — — — Effect of dilutive common stock warrants outstanding 318,957 — — — Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted 166,104,259 8,837,011 66,393,538 8,366,464 Net income (loss) per share attributable to common stockholders, diluted $ 0.05 $ (4.24) $ (1.13) $ (12.42) The following potentially dilutive shares were excluded from the computation of diluted net income (loss) per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Convertible preferred stock — 115,287,015 — 115,287,015 Common stock options 8,099,055 27,718,087 24,168,836 27,718,087 Restricted stock units 303,643 640,348 4,052,914 640,348 Convertible preferred stock warrants — 735,760 — 735,760 Common stock warrants 403,700 688,349 900,147 688,349 Private and Public Placement Warrants 14,750,000 — 14,750,000 — Earn-Out Shares 13,999,960 — 13,999,960 — Shares subject to repurchase — 198,414 — 198,414 Total 37,556,358 145,267,973 57,871,857 145,267,973

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events In October 2022, the Company’s Board of Directors approved the exchange of 12,977,484 options, with a weighted average exercise price of $3.24 for 9,582,252 RSUs due to the Option Exchange. The Company is currently assessing the accounting treatment and related impacts from the Option Exchange. The Company sold 698,992 shares of Class A common stock to Yorkville under the SEPA discussed in Note 9 for gross proceeds of $2.3 million which settled on October 3, 2022. On November 10, 2022, the Company entered into a subscription agreement (the “HGI Subscription Agreement”) with HCI Grove LLC (“HGI”), pursuant to which, among other things, the Company agreed to issue and sell, on November 15, 2022, to HGI 1,984,126 shares of the Company’s Class A common stock for aggregate proceeds of $2.5 million. Under the terms of the HGI Subscription Agreement, the Company is required to file a registration statement for the Subscribed Shares upon the Company becoming eligible to file a registration statement on Form S-3 and in any event prior to July 15, 2023 (the “Subscribed Shares Registration Statement”). The HGI Subscription Agreement also provides that the Company will issue additional shares of the Company’s Class A common stock to HGI in the event that the volume weighted average price of the Company’s Class A common stock is less than $1.26 during the three trading days commencing on the first trading day after (i) the Company files the Subscribed Shares Registration Statement (the “Registration Date”), (ii) the three-month anniversary of the Registration Date, (iii) the six-month anniversary of the Registration Date, or (iv) the nine-month anniversary of the Registration Date (“Measurement Periods” and each “Measurement Period”) upon HGI’s election to receive such additional shares (the “HGI Additional Shares”). HGI may use all or a portion of each Subscribed Share once to determine the amount of any issuance of Additional Shares in connection with the Measurement Periods such that HGI may utilize, for example, half of the Subscribed Shares to receive further Additional Shares, and leave the remaining half of the Subscribed Shares available to utilize in connection with the remaining Measurement Periods. HGI must elect to receive HGI Additional Shares for one Measurement Period, or the right lapses or is superseded by the next measurement period. The Company is currently assessing the accounting for the obligation to issue these potential additional shares, if any.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation and Liquidity	Basis of Presentation and Liquidity The Company’s unaudited condensed consolidated financial statements (the “condensed consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiary in which it holds controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation. These condensed consolidated financial statements have been prepared in accordance with GAAP applicable to interim financial statements. These financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. As such, the information included herein should
Comprehensive Loss	Comprehensive LossComprehensive loss represents all changes in stockholders’ deficit. The Company’s net income (loss) was equal to its comprehensive loss for all periods presented.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. These estimates made by management include the determination of reserves amounts for the Company’s inventories on hand, useful life of intangible assets, sales returns and allowances and certain assumptions used in the valuation of equity awards, the estimated fair value of common stock liability classified Public and Private Placement Warrants, the fair value of Earn-Out liabilities, and stock-based compensation expense. Actual results could differ from those estimates, and such estimates could be material to the Company’s financial position and the results of operations. The novel coronavirus (“COVID-19”) pandemic has created significant global economic uncertainty and resulted in the slowdown of economic activity. As of the date of issuance of these condensed consolidated financial statements, the extent to which COVID-19 may impact the future financial condition or results of operations is still uncertain. The Company is not aware of any specific event or circumstance that would require revisions to estimates, updates to judgments, or adjustments to the carrying value of assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the condensed consolidated financial statements.
Concentration of Risks	Concentration of Risks Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company maintains the majority of its cash and cash equivalents in accounts with one financial institution within the United States, generally in the form of demand accounts. Deposits in this institution may exceed federally insured limits. Management believes minimal credit risk exists with respect to this financial institution and the Company has not experienced any losses on such amounts.
Revenue Recognition	Revenue Recognition The Company primarily generates revenue from the sale of both third-party and Grove Brands products through its DTC platform. Customers purchase products through the website or mobile application through a combination of directly selecting items from the catalog, items that are suggested by the Company’s recurring shipment recommendation engine, and features that appear in marketing on-site, in emails and on the Company’s mobile application. Most customers purchase a combination of products recommended by the Company based on previous purchases and new products discovered through marketing or catalog browsing. Customers can have orders auto-shipped to them on a specified date or shipped immediately through an option available on the website and mobile application. In order to reduce the environmental impact of each shipment, the Company has a minimum total sales order value threshold policy which is required to be met before the order qualifies for shipment. Payment is collected upon finalizing the order. The products are subsequently packaged and shipped to fill the order. Customers can customize future purchases by selecting products they want to receive on a specified cadence or by selecting products for immediate shipment. The Company also offers a VIP membership to its customers for an annual fee which includes the rights to free shipping, free gifts and early access to exclusive sales, all of which are available at the customers’ option, should they elect to make future purchases of the Company’s products within their annual VIP membership benefit period. Many customers receive a free 60-day VIP membership for trial purposes, typically upon their first qualifying order. After the expiration of this free trial VIP membership period, customers will be charged their annual VIP membership fee, which automatically renews annually, until cancelled. The customer is alerted before any VIP membership renews. In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods, in an amount that reflects the consideration that it expects to receive in exchange for those goods. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration, if any, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods it transfers to a customer. A contract with a customer exists when the customer submits an order online for the Company’s products. Under this arrangement, there is one performance obligation which is the obligation for the Company to fulfill the order. Product revenue is recognized when control of the goods is transferred to the customer, which occurs upon the Company’s delivery to a third-party carrier. The VIP membership provides customers with a suite of benefits that are only accessible to them at their option, upon making a future qualifying order of the Company’s products. The VIP membership includes free shipping, a select number of free products and early access to exclusive sales. Under ASC 606, sales arrangements that include rights to additional goods or services that are exercisable at a customer’s discretion are generally considered options; therefore, the Company must assess whether these options provide a material right to the customer and if so, they are considered a performance obligation. The Company concluded that its VIP membership benefits include two material rights, one related to the future discount (i.e., free shipping) on the price of the customer’s qualifying order(s) over the membership period and the second one relating to a certain number of free products provided at pre-set intervals within the VIP membership benefit period, that will only ship with a customer’s next qualifying order (i.e., bundled). At inception of the VIP membership benefit period, the Company allocates the VIP membership fee to each of the two material rights using a relative standalone selling price basis. Generally, standalone selling prices are determined based on the observable price of the good or service when sold separately to non-VIP customers and the estimated number of shipments and free products per benefit period. The Company also considers the likelihood of redemption when determining the standalone selling price for free products and then recognize these allocated amounts upon the shipment of a qualifying customer order. To date, customers buying patterns closely approximate a ratable revenue attribution method over the customers VIP Membership period.
Customer Referral Credits	Customer Referral CreditsThe Company has a customer referral program under which credits are issued for future purchases to customers when the referral results in the generation of a new customer order. The Company records a liability at the time of issuing the credit and reduce the liability upon application of the credit to a customer’s purchase.
Fulfillment Costs	Fulfillment Costs Fulfillment costs represent those costs incurred in operating and staffing the Company’s fulfillment centers, including costs attributable to receiving, inspecting and warehousing inventories, picking, packaging, and preparing customer orders for shipment (“Fulfillment Labor”), shipping and handling expenses, packaging materials costs and payment processing and related transaction costs.
Warrant Liabilities	Warrant Liabilities The Company classifies Private Placement Warrants and Public Warrants (both defined and discussed in Note 9, Common Stock and Warrants) as liabilities. At the end of each reporting period, changes in fair value during the period are recognized within the condensed consolidated statements of operations. The Company will continue to adjust the warrant liability for changes in the fair value until the earlier of a) the exercise or expiration of the warrants or b) the redemption of the warrants, at which time the warrants will be reclassified to additional paid-in capital.
Fair Value Measurement	The Company measures certain financial assets and liabilities at fair value on a recurring basis. The Company determines fair value based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. These levels are: Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; Level 2 – Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and Level 3 – Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data. Financial instruments consist of cash equivalents, accounts payable, accrued liabilities, debt and convertible preferred stock warrant liability, Additional Shares, Earn-Out Shares and Public and Private Placement Warrants. Cash equivalents, convertible preferred stock warrant liability, Earn-Out Shares and Public and Private Placement Warrant are stated at fair value on a recurring basis. Accounts payable and accrued liabilities are stated at their carrying value, which approximates fair value due to the short period time to the expected receipt or payment. The carrying amount of the Company’s outstanding debt approximates the fair value as the debt bears interest at a rate that approximates prevailing market rate.
Contingencies	ContingenciesThe Company records loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company also discloses material contingencies when a loss is not probable but reasonably possible. Accounting for contingencies requires the Company to use judgment related to both the likelihood of a loss and the estimate of the amount or range of loss. Although the Company cannot predict with assurance the outcome of any litigation or non-income-based tax matters, the Company does not believe there are currently any such actions that, if resolved unfavorably, would have a material impact on the Company’s financial position, operating results or cash flows

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Disaggregation of Revenue	The following table sets forth revenue by product type (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Revenue, net: Grove Brands $ 36,425 $ 45,762 $ 121,489 $ 145,516 Third-party products 41,308 49,416 126,002 150,905 Total revenue, net $ 77,733 $ 95,178 $ 247,491 $ 296,421

Fair Value Measurements and F_2

Fair Value Measurements and Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis as of September 30, 2022 and December 31, 2021 by level within the fair value hierarchy (in thousands): September 30, 2022 Level 1 Level 2 Level 3 Total Financial Assets: Cash equivalents: Money market funds $ 102,094 $ — $ — $ 102,094 Total $ 102,094 $ — $ — $ 102,094 Financial Liabilities: Earn-Out Shares — — 24,345 24,345 Public Warrants 1,851 — — 1,851 Private Placement Warrants — 1,541 — 1,541 Total $ 1,851 $ 1,541 $ 24,345 $ 27,737 December 31, 2021 Level 1 Level 2 Level 3 Total Financial Assets: Cash equivalents: Money market funds $ 77,771 $ — $ — $ 77,771 Total $ 77,771 $ — $ — $ 77,771 Financial Liabilities: Convertible preferred stock warrant liability $ — $ — $ 4,787 $ 4,787 Total $ — $ — $ 4,787 $ 4,787
Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	The following table provides a summary of changes in the estimated fair value of the Additional Shares liability (in thousands): Balance at December 31, 2021 $ — Assumption of Additional Shares liability 15,340 Change in fair value 970 Settlement of Additional Shares liability (16,310) Balance at September 30, 2022 $ — The following table provides a summary of changes in the estimated fair value of the Earn-Out liability (in thousands): Balance at December 31, 2021 $ — Assumption of Earn-Out liability 70,481 Change in fair value (46,136) Balance at September 30, 2022 $ 24,345 The fair value of the preferred stock warrant liability is determined using the Black-Scholes option pricing model, which involve inherent uncertainties and the application of management’s judgment. The following table provides a summary of changes in the estimated fair value of the preferred stock warrant liability (in thousands): Balance at December 31, 2021 $ 4,787 Change in fair value (1,616) Net exercise of preferred stock warrants (989) Balance before reclassification immediately prior to the Business Combination 2,182 Reclassification to additional paid-in capital (2,182) Balance at September 30, 2022 $ —
Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation	Private Placement Warrants Public Warrants Balance at December 31, 2021 $ — $ — Assumption of Private Placement and Public Warrants 3,350 4,025 Changes in fair value (1,809) (2,174) Balance at September 30, 2022 $ 1,541 $ 1,851

Accrued Expenses (Tables)

Accrued Expenses (Tables)	9 Months Ended
	Sep. 30, 2022
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities	Accrued expenses consisted of the following (in thousands): September 30, December 31, Inventory purchases $ 2,685 $ 4,659 Compensation and benefits 2,944 2,072 Advertising costs 1,058 2,363 Fulfillment costs 2,209 1,120 Sales taxes 1,544 1,812 Transaction costs 18,764 1,846 Other accrued expenses 6,605 6,779 Total accrued expenses $ 35,809 $ 20,651

Debt and Convertible Preferred

Debt and Convertible Preferred Stock and Common Stock Warrants (Tables)	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Schedule of Debt	The Company’s outstanding debt, net of debt discounts, consisted of the following (in thousands): September 30, December 31, Silicon Valley Bank Loan Revolver $ 5,947 $ 5,947 Silicon Valley Bank and Hercules Mezzanine Term Loan 59,383 59,237 Atel Loan Facility Draw 3 751 1,489 Atel Loan Facility Draw 4 139 260 Total debt 66,220 66,933 Less: debt, current (28,447) (10,750) Total debt, noncurrent $ 37,773 $ 56,183

Convertible Preferred Stock (Ta

Convertible Preferred Stock (Tables)	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Temporary Equity	The Company’s outstanding convertible preferred stock consisted of the following as of December 31, 2021 (in thousands, except share and per share data): Original Issue Price Shares Authorized Shares Outstanding Net Carrying Value Liquidation Preference Series Seed $ 0.5245 9,693,116 9,693,115 $ 3,943 $ 5,084 Series A 0.5245 14,130,360 14,069,657 5,240 7,379 Series B 1.2450 12,689,363 12,563,418 15,545 15,642 Series C 2.4144 15,635,550 15,324,913 36,917 37,000 Series C-1 3.1669 8,554,106 8,554,106 27,003 27,090 Series D 7.0135 20,196,682 19,961,423 136,618 140,000 Series D-1 9.0731 5,314,209 5,314,209 48,146 48,216 Series D-2 6.1850 14,551,371 14,551,370 89,638 90,000 Series E 8.4672 14,762,823 14,762,823 124,868 125,000 Total 115,527,580 114,795,034 $ 487,918 $ 495,411

Common Stock and Warrants (Tabl

Common Stock and Warrants (Tables)	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Schedule of Stockholders' Equity Note, Warrants or Rights	As of September 30, 2022, the following Warrants were outstanding: Warrant Type Shares Exercise Price Public Warrants 8,050,000 $ 11.50 Private Placement Warrants 6,700,000 $ 11.50
Schedule of Reserved for Issuance	The Company has the following shares of common stock reserved for future issuance, on an as-if converted basis: September 30, 2022 December 31, 2021 Class A Common Stock Class B Common Stock Class A Common Stock Class B Common Stock Convertible preferred stock — — — 115,287,015 Convertible preferred stock warrants — — — 735,760 Private Placement Warrants 6,700,000 — — — Public Warrants 8,050,000 — — — Backstop Warrants 3,875,028 — — — Common Stock Warrants — 900,147 — 688,349 Outstanding Stock Options 9,225,954 14,942,882 — 27,882,520 Outstanding Restricted Stock Units 4,252,388 1,045,063 — 1,777,183 Remaining Shares available for issuance under 2016 Equity Incentive Plan — — — 1,070,974 Remaining Shares available for issuance under 2022 Equity Incentive Plan 25,403,278 — — — Shares available for issuance under 2022 Employee Stock Purchase Plan 3,274,070 — — — Total shares of common stock reserved 60,780,718 16,888,092 — 147,441,801

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Share-Based Payment Arrangement, Option, Activity	Stock option activity under the 2016 Plan is as follows (in thousands, except share and per share amounts): Options Outstanding Number of Options Weighted–Average Exercise Price Weighted-Average Remaining Contractual Life (years) Aggregate Intrinsic Value Balance – December 31, 2021 23,708,957 $ 3.05 7.99 $ 125,429 Recapitalization 4,173,563 (0.46) Balance – December 31, 2021 27,882,520 2.59 7.99 125,429 Exercised (216,856) 1.61 Cancelled/forfeited (3,496,828) 3.30 Balance – September 30, 2022 24,168,836 2.50 6.67 12,319 Options vested and exercisable – September 30, 2022 16,796,373 $ 2.50 5.98 $ 11,863
Schedule of Restricted Common Stock	A summary of the restricted common stock is as follows: Number of Options Weighted–Average Exercise Price Outstanding and unvested as of December 31, 2021 69,513 $ 2.25 Recapitalization 12,237 (0.33) Outstanding and unvested as of December 31, 2021 81,750 1.92 Vested (65,211) 1.92 Repurchase of early exercise (16,539) 1.92 Outstanding and unvested as of September 30, 2022 — $ —
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions	The fair value of stock option awards granted to employees was estimated at the date of grant using the Black-Scholes option-pricing model, with the following assumptions: Three Months Ended September 30, 2021 Nine Months Ended September 30, 2021 Fair value of common stock $6.91 $5.06 – $6.91 Expected term (in years) 5.64 – 6.10 5.00 – 6.28 Volatility 65.74% – 65.96% 62.33% – 75.19% Risk-free interest rate 0.81% – 0.88% 0.50% – 1.16% Dividend yield — —
Schedule of Performance-based Restricted Stock Units Activity	Performance-based restricted stock units activity under the 2016 Plan is as follows: Number of shares Weighted–Average Grant Date Fair Value Per Share Unvested – December 31, 2021 1,511,191 $ 8.62 Recapitalization 265,992 (1.29) Unvested – December 31, 2021 1,777,183 7.33 Granted 4,748,063 5.93 Vested (1,244,537) 5.94 Cancelled/forfeited (1,227,795) 6.69 Balance – September 30, 2022 4,052,914 6.15 Vested but unissued – September 30, 2022 1,244,537 $ 5.94

Net income (Loss) Per Share A_2

Net income (Loss) Per Share Attributable to Common Stockholders (Tables)	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table presents calculation of basic and diluted loss per share (in thousands, except share and per share data): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Net income (loss), basic and diluted $ 7,662 $ (37,498) $ (75,032) $ (103,909) Net income (loss) per share attributable to common stockholders, basic $ 0.05 $ (4.24) $ (1.13) $ (12.42) Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic 154,995,402 8,837,011 66,393,538 8,366,464 Effect of dilutive common stock options outstanding 10,234,953 — — — Effect of dilutive RSUs outstanding 554,947 — — — Effect of dilutive common stock warrants outstanding 318,957 — — — Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted 166,104,259 8,837,011 66,393,538 8,366,464 Net income (loss) per share attributable to common stockholders, diluted $ 0.05 $ (4.24) $ (1.13) $ (12.42)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following potentially dilutive shares were excluded from the computation of diluted net income (loss) per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Convertible preferred stock — 115,287,015 — 115,287,015 Common stock options 8,099,055 27,718,087 24,168,836 27,718,087 Restricted stock units 303,643 640,348 4,052,914 640,348 Convertible preferred stock warrants — 735,760 — 735,760 Common stock warrants 403,700 688,349 900,147 688,349 Private and Public Placement Warrants 14,750,000 — 14,750,000 — Earn-Out Shares 13,999,960 — 13,999,960 — Shares subject to repurchase — 198,414 — 198,414 Total 37,556,358 145,267,973 57,871,857 145,267,973

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Jun. 16, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Class of Stock [Line Items]
Accumulated deficit		$ 565,175		$ 565,175		$ 490,143
Cash and cash equivalents		103,791		103,791		78,376
Reverse recapitalization, proceeds received, net of transaction costs	$ 24,500			72,600
Contract with customer, refund liability, current		100		100		100
Contractual liabilities		10,816		10,816		11,267
Contract with customer, referral credit, current		100		100		100
Fulfillment cost		19,500	$ 23,500	64,200	$ 72,500
Deferred Revenue
Class of Stock [Line Items]
Contractual liabilities		10,800		10,800		11,300
Contract with customer, liability, revenue recognized				10,900
Other Current Liabilities
Class of Stock [Line Items]
Contractual liabilities		300		300		$ 300
Contract with customer, liability, revenue recognized				200
Shipping and Handling
Class of Stock [Line Items]
Fulfillment cost		12,300	14,300	39,400	43,200
Fulfillment Labor
Class of Stock [Line Items]
Fulfillment cost		$ 4,300	$ 5,700	$ 15,400	$ 17,800
Revenue Benchmark | Supplier Concentration Risk | Five Suppliers
Class of Stock [Line Items]
Concentration risk, percentage		50%	50%	50%	50%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Total revenue, net	$ 77,733	$ 95,178	$ 247,491	$ 296,421
Grove Brands
Disaggregation of Revenue [Line Items]
Total revenue, net	36,425	45,762	121,489	145,516
Third-party products
Disaggregation of Revenue [Line Items]
Total revenue, net	$ 41,308	$ 49,416	$ 126,002	$ 150,905

Recapitalization - Narrative (D

Recapitalization - Narrative (Details)				1 Months Ended	6 Months Ended	9 Months Ended
	Jun. 16, 2022 USD ($) $ / shares shares	Mar. 31, 2022 USD ($) $ / shares shares	Dec. 07, 2021 USD ($) $ / shares shares	Aug. 31, 2022 shares	Jun. 30, 2022 $ / shares	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($)	Dec. 31, 2021 $ / shares
Schedule of Reverse Recapitalization [Line Items]
Reverse recapitalization, percentage of voting interests acquired	100%
Proceeds from issuance of common stock upon Closing of Business Combination | $	$ 97,100,000					$ 97,100,000	$ 0
Reverse recapitalization, proceeds received, net of transaction costs | $	$ 24,500,000					$ 72,600,000
Common stock, par value (in dollars per share) | $ / shares	$ 0.0001
Reverse recapitalization, contingent consideration, liability, earnout period	10 years
Sale of stock, number of shares available in transaction (in shares)						32,516,831
Sale of stock, number of shares issued in transaction (in shares)						40,833
Sale of stock, consideration received on transaction | $						$ 100,000
Tranche One Shares | Corvina Holdings Limited
Schedule of Reverse Recapitalization [Line Items]
Sale of stock, number of shares issued in transaction (in shares)		2,338,352
Sale of stock, consideration received on transaction | $		$ 27,500,000
Class B Common Stock
Schedule of Reverse Recapitalization [Line Items]
Common stock, par value (in dollars per share) | $ / shares	$ 0.0001					$ 0.0001		$ 0.0001
Reverse recapitalization, contingent consideration, liability (in shares)	13,999,960
Class A Common Stock
Schedule of Reverse Recapitalization [Line Items]
Common stock, par value (in dollars per share) | $ / shares						$ 0.0001		$ 0.0001
Class of warrant or right, number of securities called by each warrant or right (in shares)	1
Stock issued during period, shares, conversion of convertible securities (in shares)		2,750,000
Class A Common Stock | Corvina Holdings Limited
Schedule of Reverse Recapitalization [Line Items]
Class of warrant or right, number of securities called by each warrant or right (in shares)						1
Class of warrants or rights warrants issued during period (in shares)						3,875,028
Share price (in dollars per share) | $ / shares						$ 0.01
Class A Common Stock | Tranche Two Shares | Corvina Holdings Limited
Schedule of Reverse Recapitalization [Line Items]
Sale of stock (in dollars per share) | $ / shares		$ 10			$ 10
Sale of stock, number of shares issued in transaction (in shares)		1,671,524		3,275,182
Sale of stock, consideration received on transaction | $		$ 16,715,240
Reverse recapitalization, aggregate gross proceeds amount | $		$ 22,500,000
Number of trading days after the closing of business combination					10 days
Class A Common Stock | Private Placement
Schedule of Reverse Recapitalization [Line Items]
Sale of stock, number of shares available in transaction (in shares)			8,707,500
Sale of stock (in dollars per share) | $ / shares			$ 10
Sale of stock, consideration available on transaction | $			$ 87,075,000
Sale of stock, number of shares issued in transaction (in shares)			8,607,500
Sale of stock, consideration received on transaction | $			$ 86,075,000
Class A Common Stock | Reverse Recapitalization Tranche One
Schedule of Reverse Recapitalization [Line Items]
Reverse recapitalization, contingent consideration, liability (in shares)	7,000,173
Reverse recapitalization, contingent consideration, liability, earnout period, stock price trigger (in dollars per share) | $ / shares	$ 12.50
Reverse recapitalization contingent consideration, liability, earnout period, threshold trading days	20 days
Reverse recapitalization, contingent consideration, liability, earnout period, threshold trading day period	30 days
Class A Common Stock | Reverse Recapitalization Tranche Two
Schedule of Reverse Recapitalization [Line Items]
Reverse recapitalization, contingent consideration, liability (in shares)	6,999,787
Reverse recapitalization, contingent consideration, liability, earnout period, stock price trigger (in dollars per share) | $ / shares	$ 15
Reverse recapitalization contingent consideration, liability, earnout period, threshold trading days	20 days
Reverse recapitalization, contingent consideration, liability, earnout period, threshold trading day period	30 days
2022 Equity Incentive Plan | Class B Common Stock
Schedule of Reverse Recapitalization [Line Items]
Recapitalization exchange ratio	1.1760

Fair Value Measurements and F_3

Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	$ 102,094	$ 77,771
Financial Liabilities:	27,737	4,787
Earn-Out Shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial Liabilities:	24,345
Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial Liabilities:	1,851
Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial Liabilities:	1,541
Convertible preferred stock warrant liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial Liabilities:		4,787
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	102,094	77,771
Financial Liabilities:	1,851	0
Level 1 | Earn-Out Shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial Liabilities:	0
Level 1 | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial Liabilities:	1,851
Level 1 | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial Liabilities:	0
Level 1 | Convertible preferred stock warrant liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial Liabilities:		0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Financial Liabilities:	1,541	0
Level 2 | Earn-Out Shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial Liabilities:	0
Level 2 | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial Liabilities:	0
Level 2 | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial Liabilities:	1,541
Level 2 | Convertible preferred stock warrant liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial Liabilities:		0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Financial Liabilities:	24,345	4,787
Level 3 | Earn-Out Shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial Liabilities:	24,345
Level 3 | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial Liabilities:	0
Level 3 | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial Liabilities:	0
Level 3 | Convertible preferred stock warrant liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial Liabilities:		4,787
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	102,094	77,771
Money market funds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	102,094	77,771
Money market funds | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Money market funds | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	$ 0	$ 0

Fair Value Measurements and F_4

Fair Value Measurements and Fair Value of Financial Instruments - Narrative (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Additional Share | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases	$ 15,340
Changes in fair value	970
Earn-Out Shares | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases	70,481
Changes in fair value	(46,136)
Convertible preferred stock warrant liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Changes in fair value	(1,600)	$ 1,500
Convertible preferred stock warrant liability | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Changes in fair value	$ (1,616)

Fair Value Measurements and F_5

Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Additional Share | Level 3
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance at December 31, 2021	$ 0
Assumption	15,340
Changes in fair value	970
Settlement of Additional Shares liability	(16,310)
Balance at September 30, 2022	0
Earn-Out Shares | Level 3
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance at December 31, 2021	0
Assumption	70,481
Changes in fair value	(46,136)
Balance at September 30, 2022	24,345
Convertible preferred stock warrant liability
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Changes in fair value	(1,600)	$ 1,500
Convertible preferred stock warrant liability | Level 3
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance at December 31, 2021	4,787
Changes in fair value	(1,616)
Net exercise of preferred stock warrants	989
Balance at September 30, 2022	0
Convertible preferred stock warrant liability | Level 3 | Previously Reported
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance at September 30, 2022	2,182
Convertible preferred stock warrant liability | Level 3 | Revision of Prior Period, Adjustment
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance at September 30, 2022	$ 2,182

Fair Value Measurements and F_6

Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Private Placement Warrants | Level 2
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Observable Input Reconciliation [Roll Forward]
Balance at December 31, 2021	$ 0
Assumption of Private Placement and Public Warrants	3,350
Changes in fair value	(1,809)
Balance at September 30, 2022	1,541
Public Warrants | Level 1
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Observable Input Reconciliation [Roll Forward]
Balance at December 31, 2021	0
Assumption of Private Placement and Public Warrants	4,025
Changes in fair value	(2,174)
Balance at September 30, 2022	$ 1,851

Accrued Expenses - Schedule of

Accrued Expenses - Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Payables and Accruals [Abstract]
Inventory purchases	$ 2,685	$ 4,659
Compensation and benefits	2,944	2,072
Advertising costs	1,058	2,363
Fulfillment costs	2,209	1,120
Sales taxes	1,544	1,812
Transaction costs	18,764	1,846
Other accrued expenses	6,605	6,779
Accrued expenses	$ 35,809	$ 20,651

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Total debt	$ 66,220	$ 66,933
Debt, current	(28,447)	(10,750)
Total debt, noncurrent	37,773	56,183
Silicon Valley Bank Loan Revolver | Revolving Credit Facility
Debt Instrument [Line Items]
Long-term line of credit	5,947	5,947
Silicon Valley Bank and Hercules Mezzanine Term Loan | Mezzanine Loan And Equity Security
Debt Instrument [Line Items]
Other long-term debt	59,383	59,237
Atel | Tranche Three | Atel Loan Facility
Debt Instrument [Line Items]
Other long-term debt	800
Atel | Tranche Four | Atel Loan Facility
Debt Instrument [Line Items]
Other long-term debt	100
Atel | Atel Loan Facility Draw 3
Debt Instrument [Line Items]
Other long-term debt	751	1,489
Atel | Atel Loan Facility Draw 4
Debt Instrument [Line Items]
Other long-term debt	$ 139	$ 260

Debt - Narrative (Details)

Debt - Narrative (Details) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
	Apr. 30, 2021 USD ($) installment	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Mar. 31, 2023	May 31, 2022	Dec. 31, 2021 USD ($)	Dec. 31, 2016 USD ($)
Debt Instrument [Line Items]
Loss on extinguishment of debt		$ 0	$ 0	$ 0	$ 1,027
Atel Loan Facility Draw 4
Debt Instrument [Line Items]
Debt instrument, interest rate, effective percentage		19.23%		19.23%
Atel Loan Facility Draw 3
Debt Instrument [Line Items]
Debt instrument, interest rate, effective percentage		19.23%		19.23%
Silicon Valley Bank Loan Revolver | Revolving Credit Facility
Debt Instrument [Line Items]
Long-term line of credit		$ 5,947		$ 5,947				$ 5,947
Silicon Valley Bank and Hercules Mezzanine Term Loan | Minimum
Debt Instrument [Line Items]
Percentage of aggregate term loan advance increase							6.75%
Silicon Valley Bank and Hercules Mezzanine Term Loan | Maximum
Debt Instrument [Line Items]
Percentage of aggregate term loan advance increase							8.75%
Loan And Security Agreement | Silicon Valley Bank Loan Revolver | Growth Capital Advance | Prime Rate
Debt Instrument [Line Items]
Debt instrument, face amount									$ 3,900
Loan And Security Agreement | Silicon Valley Bank Loan Revolver | Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity									$ 25,000
Loan revolver borrower capacity as a percentage of inventory balance									60%
Loan And Security Agreement | Silicon Valley Bank Loan Revolver | Letter of Credit
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity									$ 6,000
Amendment to the Loan And Security Agreement
Debt Instrument [Line Items]
Loss on extinguishment of debt			1,000
Amendment to the Loan And Security Agreement | Silicon Valley Bank Loan Revolver | Revolving Credit Facility
Debt Instrument [Line Items]
Loan revolver borrower capacity as a percentage of inventory balance	65%
Line of credit facility, unused capacity, commitment fee percentage	0.20%
Letters of credit outstanding, amount		3,100		3,100
Credit card outstanding		1,500		1,500
Long-term line of credit		$ 5,900		$ 5,900
Debt instrument, interest rate, effective percentage		5.60%		5.60%
Amendment to the Loan And Security Agreement | Silicon Valley Bank Loan Revolver | Revolving Credit Facility | Forecast
Debt Instrument [Line Items]
Long-term debt, percentage bearing variable interest, percentage rate						3.25%
Amendment to the Loan And Security Agreement | Silicon Valley Bank Loan Revolver | Letter of Credit
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 10,000
Minimum liquidity to be maintained	$ 45,000
Mezzanine Loan and Security Agreement | Silicon Valley Bank Loan Revolver
Debt Instrument [Line Items]
Percentage of aggregate term loan advance increase	51%
Mezzanine Loan and Security Agreement | Silicon Valley Bank and Hercules Mezzanine Term Loan
Debt Instrument [Line Items]
Debt instrument, face amount	$ 60,000
Long-term debt, percentage bearing variable interest, percentage rate	8.75%
Other long-term debt		$ 60,000		$ 60,000
Debt instrument, basis spread on variable rate	5.50%
Debt instrument, number of monthly installments | installment	30
Percentage of aggregate term loan advance increase	6.75%
Mezzanine Loan and Security Agreement | Silicon Valley Bank and Hercules Mezzanine Term Loan | Minimum
Debt Instrument [Line Items]
Debt instrument, interest rate, effective percentage		15.78%		15.78%
Mezzanine Loan and Security Agreement | Silicon Valley Bank and Hercules Mezzanine Term Loan | Maximum
Debt Instrument [Line Items]
Debt instrument, interest rate, effective percentage		18.83%		18.83%
Mezzanine Loan and Security Agreement | Silicon Valley Bank and Hercules Mezzanine Term Loan | Tranche One
Debt Instrument [Line Items]
Other long-term debt	$ 25,000
Mezzanine Loan and Security Agreement | Silicon Valley Bank and Hercules Mezzanine Term Loan | Tranche Two
Debt Instrument [Line Items]
Other long-term debt			$ 25,000		$ 25,000
Mezzanine Loan and Security Agreement | Silicon Valley Bank and Hercules Mezzanine Term Loan | Tranche Three
Debt Instrument [Line Items]
Long-term line of credit								$ 10,000
Mezzanine Loan and Security Agreement | Hercules Capital Inc
Debt Instrument [Line Items]
Percentage of aggregate term loan advance increase	49%
Atel Loan Facility | Atel | Tranche Three
Debt Instrument [Line Items]
Other long-term debt		$ 800		$ 800
Atel Loan Facility | Atel | Tranche Four
Debt Instrument [Line Items]
Other long-term debt		$ 100		$ 100

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Long-Term Purchase Commitment [Line Items]
Purchase obligation	$ 17.9	$ 36.1
Standby Letters of Credit
Long-Term Purchase Commitment [Line Items]
Line of credit facility, maximum borrowing capacity	$ 3.1	$ 3.1

Convertible Preferred Stock - T

Convertible Preferred Stock - Temporary Equity (Details) - USD ($) $ / shares in Units, $ in Thousands	Sep. 30, 2022	Jun. 16, 2022	Dec. 31, 2021
Temporary Equity [Line Items]
Temporary equity, shares authorized (in shares)	100,000,000	100,000,000	115,527,580
Temporary equity, shares outstanding (in shares)	0		114,795,034
Net Carrying Value	$ 0		$ 487,918
Liquidation Preference			$ 495,411
Series Seed
Temporary Equity [Line Items]
Original issue price (in dollars per share)			$ 0.5245
Temporary equity, shares authorized (in shares)			9,693,116
Temporary equity, shares outstanding (in shares)			9,693,115
Net Carrying Value			$ 3,943
Liquidation Preference			$ 5,084
Series A
Temporary Equity [Line Items]
Original issue price (in dollars per share)			$ 0.5245
Temporary equity, shares authorized (in shares)			14,130,360
Temporary equity, shares outstanding (in shares)			14,069,657
Net Carrying Value			$ 5,240
Liquidation Preference			$ 7,379
Series B
Temporary Equity [Line Items]
Original issue price (in dollars per share)			$ 1.2450
Temporary equity, shares authorized (in shares)			12,689,363
Temporary equity, shares outstanding (in shares)			12,563,418
Net Carrying Value			$ 15,545
Liquidation Preference			$ 15,642
Series C
Temporary Equity [Line Items]
Original issue price (in dollars per share)			$ 2.4144
Temporary equity, shares authorized (in shares)			15,635,550
Temporary equity, shares outstanding (in shares)			15,324,913
Net Carrying Value			$ 36,917
Liquidation Preference			$ 37,000
Series C-1
Temporary Equity [Line Items]
Original issue price (in dollars per share)			$ 3.1669
Temporary equity, shares authorized (in shares)			8,554,106
Temporary equity, shares outstanding (in shares)			8,554,106
Net Carrying Value			$ 27,003
Liquidation Preference			$ 27,090
Series D
Temporary Equity [Line Items]
Original issue price (in dollars per share)			$ 7.0135
Temporary equity, shares authorized (in shares)			20,196,682
Temporary equity, shares outstanding (in shares)			19,961,423
Net Carrying Value			$ 136,618
Liquidation Preference			$ 140,000
Series D-1
Temporary Equity [Line Items]
Original issue price (in dollars per share)			$ 9.0731
Temporary equity, shares authorized (in shares)			5,314,209
Temporary equity, shares outstanding (in shares)			5,314,209
Net Carrying Value			$ 48,146
Liquidation Preference			$ 48,216
Series D-2
Temporary Equity [Line Items]
Original issue price (in dollars per share)			$ 6.1850
Temporary equity, shares authorized (in shares)			14,551,371
Temporary equity, shares outstanding (in shares)			14,551,370
Net Carrying Value			$ 89,638
Liquidation Preference			$ 90,000
Series E
Temporary Equity [Line Items]
Original issue price (in dollars per share)			$ 8.4672
Temporary equity, shares authorized (in shares)			14,762,823
Temporary equity, shares outstanding (in shares)			14,762,823
Net Carrying Value			$ 124,868
Liquidation Preference			$ 125,000

Convertible Preferred Stock - N

Convertible Preferred Stock - Narrative (Details)	Jun. 16, 2022
Class B Common Stock | 2022 Equity Incentive Plan
Temporary Equity [Line Items]
Recapitalization exchange ratio	1.1760

Common Stock and Warrants - Nar

Common Stock and Warrants - Narrative (Details) $ / shares in Units, $ in Thousands		9 Months Ended
	Jul. 18, 2022 USD ($)	Sep. 30, 2022 USD ($) $ / shares shares	Jul. 16, 2022 $ / shares shares	Jun. 16, 2022 vote $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Class of Warrant or Right [Line Items]
Common stock, par value (in dollars per share) | $ / shares				$ 0.0001
Common stock, shares authorized (in shares)				900,000,000
Temporary equity, shares authorized (in shares)		100,000,000		100,000,000	115,527,580
Number of shares converted				1
Preferred stock, shares outstanding (in shares)		0
Preferred stock, shares issued (in shares)		0
Derivative liabilities | $		$ 27,737			$ 0
Purchase agreement, equity interests issuable, not yet issued | $	$ 100,000
Purchase agreement, equity interests issuable, not yet issued, transaction period	36 months
Purchase agreement, volume weighted average price, percentage	97.55%
Purchase agreement, deferred transaction cost | $	$ 700
Sale of stock, number of shares issued in transaction (in shares)		40,833
Sale of stock, consideration received on transaction | $		$ 100
Sale of stock, number of shares available in transaction (in shares)		32,516,831
Private Placement Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)		6,700,000
Exercise price (in dollars per share) | $ / shares		$ 11.50
Derivative liabilities | $		$ 3,400
Number of days after the completion of an initial business combination		30 days
Public Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares)		8,050,000
Exercise price (in dollars per share) | $ / shares		$ 11.50
Derivative liabilities | $		$ 3,400
Class B Common Stock
Class of Warrant or Right [Line Items]
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001		$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)		200,000,000		200,000,000	194,046,918
Number of votes | vote				10
Common Stock
Class of Warrant or Right [Line Items]
Common stock, shares authorized (in shares)				800,000,000
Class A Common Stock
Class of Warrant or Right [Line Items]
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001			$ 0.0001
Common stock, shares authorized (in shares)		600,000,000		600,000,000	0
Number of votes | vote				1
Number of shares converted				1
Class A Common Stock | Public Warrants
Class of Warrant or Right [Line Items]
Number of warrant or right, entitles to purchase (in shares)			1
Class of warrants redemption notice period			30 days
Class of warrants or rights redemption price per unit (in dollars per share) | $ / shares			$ 0.01
Share redemption trigger price (in dollars per share) | $ / shares			$ 18
Class A Common Stock | Public Warrants | Minimum
Class of Warrant or Right [Line Items]
Class of warrant or right redemption threshold consecutive trading days			20 days
Class A Common Stock | Public Warrants | Maximum
Class of Warrant or Right [Line Items]
Class of warrant or right redemption threshold consecutive trading days			30 days
2022 Equity Incentive Plan | Class B Common Stock
Class of Warrant or Right [Line Items]
Recapitalization exchange ratio				1.1760

Common Stock and Warrants - Sch

Common Stock and Warrants - Schedule of Stockholders' Equity Note, Warrants or Rights (Details)	Sep. 30, 2022 $ / shares shares
Public Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares) | shares	8,050,000
Exercise price (in dollars per share) | $ / shares	$ 11.50
Private Placement Warrants
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding (in shares) | shares	6,700,000
Exercise price (in dollars per share) | $ / shares	$ 11.50

Common Stock and Warrants - S_2

Common Stock and Warrants - Schedule of Reserved for Issuance (Details) - shares	Sep. 30, 2022	Dec. 31, 2021
Class A Common Stock
Class of Warrant or Right [Line Items]
Convertible preferred stock, shares reserved for future issuance (in shares)	0	0
Convertible preferred stock warrant, shares reserved for future issuance (in shares)	0	0
Private placement warrant, shares reserved for future issuance (in shares)	6,700,000	0
Public warrant, shares reserved for future issuance (in shares)	8,050,000	0
Backstop warrant, shares reserved for future issuance (in shares)	3,875,028	0
Common stock warrant, shares reserved for future issuance (in shares)	0	0
Outstanding stock option, shares reserved for future issuance (in shares)	9,225,954	0
Outstanding restricted stock unit, shares reserved for future issuance (in shares)	4,252,388	0
Shares available for issuance under 2022 Employee Stock Purchase Plan (in shares)	3,274,070	0
Total shares of common stock reserved (in shares)	60,780,718	0
Class B Common Stock
Class of Warrant or Right [Line Items]
Convertible preferred stock, shares reserved for future issuance (in shares)	0	115,287,015
Convertible preferred stock warrant, shares reserved for future issuance (in shares)	0	735,760
Private placement warrant, shares reserved for future issuance (in shares)	0	0
Public warrant, shares reserved for future issuance (in shares)	0	0
Backstop warrant, shares reserved for future issuance (in shares)	0	0
Common stock warrant, shares reserved for future issuance (in shares)	900,147	688,349
Outstanding stock option, shares reserved for future issuance (in shares)	14,942,882	27,882,520
Outstanding restricted stock unit, shares reserved for future issuance (in shares)	1,045,063	1,777,183
Shares available for issuance under 2022 Employee Stock Purchase Plan (in shares)	0	0
Total shares of common stock reserved (in shares)	16,888,092	147,441,801
2016 Equity Incentive Plan | Class A Common Stock
Class of Warrant or Right [Line Items]
Shares available for future issuance under equity incentive plan (in shares)	0	0
2016 Equity Incentive Plan | Class B Common Stock
Class of Warrant or Right [Line Items]
Shares available for future issuance under equity incentive plan (in shares)	0	1,070,974
2022 Equity Incentive Plan | Class A Common Stock
Class of Warrant or Right [Line Items]
Shares available for future issuance under equity incentive plan (in shares)	25,403,278	0
2022 Equity Incentive Plan | Class B Common Stock
Class of Warrant or Right [Line Items]
Shares available for future issuance under equity incentive plan (in shares)	0	0

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) $ / shares in Units, $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Feb. 28, 2021 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) shares	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) shares	Dec. 31, 2021 USD ($)	Jun. 16, 2022	Apr. 30, 2022 shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Fair value of common stock (in dollars per share) | $ / shares				$ 3.71
Share-based compensation arrangement by share-based payment award, options, grants in period, gross | shares				0
Share-based compensation arrangement by share-based payment award, options, vested in period, fair value				$ 10.2	$ 9.4
Share-based compensation arrangement by share-based payment award, options, exercisable, aggregate intrinsic value		$ 1	$ 2.6	1	2.6
Share-based compensation arrangement by share-based payment award, fair value of shares subject to repurchase obligation				0		$ 0.2
Stock-based compensation expense		9.8	$ 3.6	34.3	$ 10.9
Share-based payment arrangement, nonvested award, cost not yet recognized, amount		33.3		$ 33.3
Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition (in years)				2 years 2 months 12 days
2022 Equity Incentive Plan | Class B Common Stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Recapitalization exchange ratio							1.1760
Share-Based Payment Arrangement
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based compensation arrangement by Share-based payment award, shares issued in period (in shares) | shares				0	11,025
Market-based Stock Options
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, options, grants in period, gross | shares	1,017,170
Share-based compensation arrangement by share-based payment award, options, exercisable, weighted average exercise price (in dollars per share) | $ / shares	$ 3.77
Vesting rights, percentage	100%
Share-based compensation arrangement by share-based payment award, options, grant date, fair value	$ 5.5
Stock-based compensation expense	$ 4.6
Restricted stock units
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based payment arrangement, catch up expense		11.9
Equity Award Modifications
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based payment arrangement, plan modification, incremental cost		$ 0.5		$ 2.2
Equity Award Modifications | Sixty Days
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based payment arrangement, option, exercise price range, exercisable, weighted average remaining contractual term (in years)				60 days
Equity Award Modifications | One Year
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based payment arrangement, option, exercise price range, exercisable, weighted average remaining contractual term (in years)				1 year
Equity Award Modifications | Two Years
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based payment arrangement, option, exercise price range, exercisable, weighted average remaining contractual term (in years)				2 years
Equity Award Modifications | Ten Years
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based payment arrangement, option, exercise price range, exercisable, weighted average remaining contractual term (in years)				10 years
2016 Equity Incentive Plan
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based compensation arrangement by share-based payment award, number of shares authorized (in shares) | shares								3,500,000
2022 Equity Incentive Plan
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based compensation arrangement by share-based payment award, number of shares authorized (in shares) | shares		24,555,528		24,555,528
Share-based compensation arrangement by share-based payment award, annual percent of shares increase		0.05		0.05

Stock-Based Compensation - Shar

Stock-Based Compensation - Share-Based Payment Arrangement, Option, Activity (Details) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Number of Options
Options outstanding, beginning of period (in shares) | shares	27,882,520
Exercised (in shares) | shares	(216,856)
Forfeited and expired (in shares) | shares	(3,496,828)
Options outstanding, ending of period (in shares) | shares	24,168,836	27,882,520
Options vested and exercisable (in shares) | shares	16,796,373
Weighted–Average Exercise Price
Options outstanding, beginning of period (in dollars per share) | $ / shares	$ 2.59
Exercised (in dollars per share) | $ / shares	1.61
Forfeited and expired (in dollars per share) | $ / shares	3.30
Options outstanding, ending of period (in dollars per share) | $ / shares	2.50	$ 2.59
Options vested and exercisable (in dollars per share) | $ / shares	$ 2.50
Weighted-Average Remaining Contractual Life (years)
Options, outstanding (in years)	6 years 8 months 1 day	7 years 11 months 26 days
Options vested and exercisable (in years)	5 years 11 months 23 days
Aggregate Intrinsic Value
Options, outstanding, aggregate intrinsic value | $	$ 12,319	$ 125,429
Options, vested and exercisable, aggregate intrinsic value | $	$ 11,863
Previously Reported
Number of Options
Options outstanding, beginning of period (in shares) | shares	23,708,957
Options outstanding, ending of period (in shares) | shares		23,708,957
Weighted–Average Exercise Price
Options outstanding, beginning of period (in dollars per share) | $ / shares	$ 3.05
Options outstanding, ending of period (in dollars per share) | $ / shares		$ 3.05
Weighted-Average Remaining Contractual Life (years)
Options, outstanding (in years)		7 years 11 months 26 days
Aggregate Intrinsic Value
Options, outstanding, aggregate intrinsic value | $		$ 125,429
Revision of Prior Period, Adjustment
Number of Options
Options outstanding, beginning of period (in shares) | shares	4,173,563
Options outstanding, ending of period (in shares) | shares		4,173,563
Weighted–Average Exercise Price
Options outstanding, beginning of period (in dollars per share) | $ / shares	$ (0.46)
Options outstanding, ending of period (in dollars per share) | $ / shares		$ (0.46)

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Restricted Common Stock (Details) - Restricted Common Stock	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Number of Options
Outstanding and unvested, beginning of period (in shares) | shares	81,750
Vested (in shares) | shares	(65,211)
Repurchase of early exercise (in shares) | shares	(16,539)
Outstanding and unvested, ending of period (in shares) | shares	0
Weighted–Average Exercise Price
Outstanding and unvested, beginning of period (in dollars per share) | $ / shares	$ 1.92
Vested (in dollars per share) | $ / shares	1.92
Repurchase of early exercise (in dollars per share) | $ / shares	1.92
Outstanding and unvested, ending of period (in dollars per share) | $ / shares	$ 0
Previously Reported
Number of Options
Outstanding and unvested, beginning of period (in shares) | shares	69,513
Weighted–Average Exercise Price
Outstanding and unvested, beginning of period (in dollars per share) | $ / shares	$ 2.25
Revision of Prior Period, Adjustment
Number of Options
Outstanding and unvested, beginning of period (in shares) | shares	12,237
Weighted–Average Exercise Price
Outstanding and unvested, beginning of period (in dollars per share) | $ / shares	$ (0.33)

Stock-Based Compensation - Sc_2

Stock-Based Compensation - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions (Details) - $ / shares	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Volatility, minimum	65.74%	62.33%
Volatility, maximum	65.96%	75.19%
Risk-free interest rate, minimum	0.81%	0.50%
Risk-free interest rate, maximum	0.88%	1.16%
Dividend yield	0%	0%
Minimum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Fair value of common stock (in dollars per share)	$ 6.91	$ 5.06
Expected term (in years)	5 years 7 months 20 days	5 years
Maximum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Fair value of common stock (in dollars per share)		$ 6.91
Expected term (in years)	6 years 1 month 6 days	6 years 3 months 10 days

Stock-Based Compensation - Sc_3

Stock-Based Compensation - Schedule of Performance-based Restricted Stock Units Activity (Details) - Performance-based Restricted Stock Units	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Number of Options
Outstanding and unvested, beginning of period (in shares) | shares	1,777,183
Granted (in shares) | shares	4,748,063
Vested (in shares) | shares	1,244,537
Cancelled/forfeited (in shares) | shares	(1,227,795)
Outstanding and unvested, ending of period (in shares) | shares	4,052,914
Vested but unissued (in shares) | shares	1,244,537
Weighted–Average Exercise Price
Outstanding and unvested, beginning of period (in dollars per share) | $ / shares	$ 7.33
Granted (in dollars per share) | $ / shares	5.93
Vested (in dollars per share) | $ / shares	5.94
Cancelled/forfeited (in dollars per share) | $ / shares	6.69
Outstanding and unvested, ending of period (in dollars per share) | $ / shares	6.15
Vested but unissued (in dollars per share) | $ / shares	$ 5.94
Previously Reported
Number of Options
Outstanding and unvested, beginning of period (in shares) | shares	1,511,191
Weighted–Average Exercise Price
Outstanding and unvested, beginning of period (in dollars per share) | $ / shares	$ 8.62
Revision of Prior Period, Adjustment
Number of Options
Outstanding and unvested, beginning of period (in shares) | shares	265,992
Weighted–Average Exercise Price
Outstanding and unvested, beginning of period (in dollars per share) | $ / shares	$ (1.29)

Net income (Loss) Per Share A_3

Net income (Loss) Per Share Attributable to Common Stockholders - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income (loss), basic and diluted	$ 7,662	$ (37,498)	$ (75,032)	$ (103,909)
Net income (loss) per share attributable to common stockholders, basic (in dollars per share)	$ 0.05	$ (4.24)	$ (1.13)	$ (12.42)
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic (in shares)	154,995,402	8,837,011	66,393,538	8,366,464
Effect of dilutive common stock warrants outstanding (in shares)	318,957	0	0	0
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted (in shares)	166,104,259	8,837,011	66,393,538	8,366,464
Net income (loss) per share attributable to common stockholders, diluted (in dollars per share)	$ 0.05	$ (4.24)	$ (1.13)	$ (12.42)
Common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted average number of shares outstanding, diluted, adjustment (in shares)	10,234,953	0	0	0
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted average number of shares outstanding, diluted, adjustment (in shares)	554,947	0	0	0

Net income (Loss) Per Share A_4

Net income (Loss) Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares)	37,556,358	145,267,973	57,871,857	145,267,973
Convertible preferred stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares)	0	115,287,015	0	115,287,015
Common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares)	8,099,055	27,718,087	24,168,836	27,718,087
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares)	303,643	640,348	4,052,914	640,348
Convertible preferred stock warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares)	0	735,760	0	735,760
Common stock warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares)	403,700	688,349	900,147	688,349
Private and Public Placement Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares)	14,750,000	0	14,750,000	0
Earn-Out Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares)	13,999,960	0	13,999,960	0
Shares subject to repurchase
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total net income (loss) per share attributable to common stockholders, basic and diluted (in shares)	0	198,414	0	198,414

Subsequent Events (Details)

Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Thousands				9 Months Ended
	Nov. 15, 2022	Nov. 10, 2022	Oct. 03, 2022	Sep. 30, 2022	Oct. 31, 2022
Subsequent Event [Line Items]
Sale of stock, number of shares issued in transaction (in shares)				40,833
Sale of stock, consideration received on transaction				$ 100
Subsequent Event
Subsequent Event [Line Items]
Consulting fee expense		$ 150
Subsequent Event | HGI Warrants
Subsequent Event [Line Items]
Warrants issued (in shares)		4,525,000
Exercise price (in dollars per share)		$ 1.26
Warrant shares, shares vesting rights, percentage		40%
Warrants, covenant, quarterly net revenue		$ 100,000
Warrants, equity ownership percentage		25%
Warrant, exercise price, increase, percentage		50%
Share-Based Payment Arrangement, Option | Subsequent Event
Subsequent Event [Line Items]
Share-based compensation arrangement by share-based payment award, options, exchange, number					12,977,484
Share-based compensation arrangement by share-based payment award, options, exchange, weighted average exercise price (in dollars per share)					$ 3.24
Restricted stock units | Subsequent Event
Subsequent Event [Line Items]
Share-based compensation arrangement by share-based payment award, options, exchange, number					9,582,252
Class A Common Stock | Subsequent Event
Subsequent Event [Line Items]
Sale of stock, number of shares issued in transaction (in shares)			698,992
Sale of stock, consideration received on transaction			$ 2,300
Class A Common Stock | Subsequent Event | HGI Subscription Agreement
Subsequent Event [Line Items]
Sale of stock, number of shares issued in transaction (in shares)	1,984,126
Sale of stock, consideration received on transaction	$ 2,500
Sale of stock, covenant, volume weighted average price threshold (in dollars per share)		$ 1.26